Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - WORLDWIDE STRATEGIES INCFinancial_Report.xls
EX-32.1 - EXH 32-1 CERTIFICATION - WORLDWIDE STRATEGIES INCexh32-1_certification.htm
EX-31.1 - EXH 31-1 CERTIFICATION - WORLDWIDE STRATEGIES INCexh31-1_certification.htm
EX-31.2 - EXH 31-2 CERTIFICATION - WORLDWIDE STRATEGIES INCexh31-2_certification.htm
EX-32.2 - EXH 32-2 CERTIFICATION - WORLDWIDE STRATEGIES INCexh32-2_certification.htm
 


 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-K

 ý
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended July 31, 2012

 ¨  
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from  ___________________   to  ________________________

Commission File Number: 000-52362

Worldwide Strategies Incorporated
(Exact name of registrant as specified in its charter)

Nevada
41-0946897
(State or other jurisdiction of incorporation or organization)
(I.R.S. Employer Identification No.)
   
3801 East Florida Avenue, Suite 400, Denver, Colorado
80210
(Address of principal executive offices)
(Zip Code)

Registrant’s telephone number, including area code:  (303) 991-5887

Securities registered pursuant to Section 12(b) of the Act: None

Securities registered pursuant to Section 12(g) of the Act: Common Stock, $0.001 par value

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.  Yes ¨   No ý

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.  Yes ¨   No ý

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes ý   No ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yes ý   No ¨

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.  ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 
 

 


Large accelerated filer  o
Accelerated filer  o
Non-accelerated filer  o
Smaller reporting company  ý

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes ý   No ¨

State the aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant’s most recently completed second fiscal quarter:  $436,304 on January 31, 2012

Indicate the number of shares outstanding of each of the registrant’s classes of common equity, as of the latest practicable date: 17,523,984 on September 27, 2012.

FORWARD-LOOKING STATEMENTS

This annual report on Form 10-K contains “forward-looking statements.”  All statements other than statements of historical facts included or incorporated by reference in this report, including, without limitation, statements regarding our future financial position, business strategy, budgets, projected costs and plans and objectives of management for future operations, are forward-looking statements.  In addition, forward-looking statements generally can be identified by the use of forward-looking terminology such as “may,” “will,” “expect,” “intend,” “project,” “estimate,” “anticipate,” “believe,” or “continue” or the negative thereof or variations thereon or similar terminology.  In assessing forward-looking statements contained in this report, readers are urged to read carefully all cautionary statements, including those contained in other sections of this report.  Although we believe that the expectations reflected in such forward-looking statements are reasonable, we cannot give any assurance that such expectations will prove to be correct.  Important factors that could cause actual results to differ materially from our expectations (“Cautionary Statements”) include, but are not limited to:

·     
our ability to generate sufficient capital to complete planned acquisitions;
·     
our ability to successfully operate our business upon completion of any or all planned acquisitions;
·     
the lack of liquidity of our common stock;
·     
our ability to find and retain skilled personnel;
·     
availability of capital;
·     
the strength and financial resources of our competitors;
·     
general economic conditions; and
·     
the securities or capital markets and other factors disclosed under “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and elsewhere in this report.

All subsequent written and oral forward-looking statements attributable to us, or persons acting on our behalf, are expressly qualified in their entirety by the cautionary statements.  We assume no duty to update or revise our forward-looking statements based on changes in internal estimates or expectations or otherwise.


 
2

 

WORLDWIDE STRATEGIES INCORPORATED

FORM 10-K
FOR THE FISCAL YEAR ENDED
JULY 31, 2012

INDEX

   
Page
PART I
Item 1.
Business
4
Item 1A.
Risk Factors
5
Item 1B.
Unresolved Staff Comments
6
Item 2.
Properties
6
Item 3.
Legal Proceedings
7
Item 4.
Mine Safety Disclosures
7
     
PART II
Item 5.
Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
7
Item 6.
Selected Financial Data
8
Item 7.
Management’s Discussion and Analysis of Financial Condition and Results of Operations
8
Item 7A.
Quantitative and Qualitative Disclosures About Market Risk
10
Item 8.
Financial Statements and Supplementary Data
11
Item 9.
Changes In and Disagreements With Accountants on Accounting and Financial Disclosure
36
Item 9A.
Controls and Procedures
36
Item 9B.
Other Information
37
     
PART III
Item 10.
Directors, Executive Officers and Corporate Governance
37
Item 11.
Executive Compensation
41
Item 12.
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
43
Item 13.
Certain Relationships and Related Transactions, and Director Independence
45
Item 14.
Principal Accounting Fees and Services
45
     
PART IV
Item 15.
Exhibits, Financial Statement Schedules
46



 
3

 

PART I

ITEM 1.BUSINESS

Business Development

Worldwide Strategies Incorporated (“we”, “us”, or “our”) was originally incorporated in the State of Nevada on April 6, 1998 as Boyd Energy Corporation for the purpose of developing a mechanical lifting device that would enhance existing stripper well production.  We were unable to raise sufficient capital to carry out this business and focused instead on leasing properties and exploring for oil and gas.  We changed our name to Barnett Energy Corporation on July 17, 2001.

On July 8, 2005, pursuant to a Share Exchange Agreement with Worldwide Business Solutions Incorporated, a Colorado corporation (“WBSI”), we acquired all of the issued and outstanding capital stock of WBSI, in exchange for 2,573,335 shares of our common stock.  As a result of this share exchange, shareholders of WBSI as a group owned approximately 76.8% of the shares then outstanding, and WBSI became our wholly-owned subsidiary.  We changed our name to Worldwide Strategies Incorporated as of June 14, 2005.

For accounting purposes, the acquisition of WBSI was accounted for as a recapitalization of WBSI.  Since we had only minimal assets and no operations, the recapitalization has been accounted for as the sale of 778,539 shares of WBSI common stock for our net liabilities at the time of the transaction.  Therefore, the historical financial information prior to the date of the recapitalization is the financial information of WBSI.  WBSI was incorporated on March 1, 2005 to provide Business Process Outsourcing services.

WBSI incorporated a subsidiary, Worldwide Business Solutions Limited, in the United Kingdom under the Companies Acts 1985 and 1989, on May 31, 2005.  This U.K. subsidiary was formed for the purpose of supporting sales and marketing efforts in English-speaking countries.  While the subsidiary has a temporary office and bank accounts established, it does not yet have any employees.

On July 31, 2007, we acquired 100% of the issued and outstanding shares of Centric Rx, Inc., a Nevada corporation (“Centric”) in exchange for 2,250,000 post-reverse-split shares of our common stock.  We filed Articles of Exchange Pursuant to NRS 92A.200 effective July 31, 2007.  Centric is no longer in existence.

Effective July 31, 2007, we filed a Certificate of Change Pursuant to NRS 78.209, which decreased the number of our authorized shares of common stock from 100,000,000 to 33,333,333 and reduced the number of common shares issued and outstanding immediately prior to filing from 17,768,607 to 5,923,106.

Our Business Plans

We originally intended to offer call center services, such as technical support, language interpreting, debt collections, and help desk solutions.  Then, with the acquisition of Centric, we planned to enter the business of distributing health services and prescription drug discount cards.  As of the date hereof, our only plan is to search for merger or acquisition opportunities.  We are attempting to market the Company as a “shell company” as we believe that its status as a reporting company whose stock is quoted on the OTC Link has value.  We cannot assure you that we will be successful in this effort.

On April 28, 2011, we accepted a proposal from Euzkadi Corporation of America, S.A. (“Euzkadi”) to enter into a business combination transaction.  It is proposed that Euzkadi would acquire 80% of our then issued and outstanding shares in exchange for all of the issued and outstanding shares of Euzkadi.

Consummation of this proposed transaction will be contingent upon the satisfaction of several conditions, including the completion of a satisfactory due diligence investigation and the completion of an audit of Euzkadi’s financial statements that meet the requirements of the reporting rules and regulations of the Securities and Exchange Commission.

 
4

 
Employees

As of September 27, 2012, we employed a total of 2 persons, both of which were full-time.  None of our employees are covered by a collective bargaining agreement.

ITEM 1A.RISK FACTORS

Risks Relating To Our Business and Marketplace

We must obtain financing to continue operations.  We must engage in debt and/or equity financing in order to continue operations.  We do not know the terms on which any financing might be available or if such financing is available on any terms.  Such terms may be detrimental to the interests of our existing shareholders.  The value of an investment in our common stock could be reduced.  Interest on debt securities could increase costs and negatively impacts operating results.  Preferred stock could be issued in series from time to time with such designations, rights, preferences, and limitations as needed to raise capital.  The terms of preferred stock could be more advantageous to those investors than to the holders of common stock.  In addition, if we need to raise more equity capital from the sale of common stock, institutional or other investors may negotiate terms at least as, and possibly more, favorable than the terms given to our current investors.  Shares of common stock that we sell could be sold into the market, which could adversely affect market price.

We are seeking other merger and acquisition opportunities.  We may not be able to successfully acquire or merge with another business.  Any acquisition or merger that we undertake will require an unspecified amount of additional capital expenditure in the form of planning, due diligence, legal, and accounting fees.  We have no substantial experience in completing acquisitions of or mergers with other businesses, and we may be unable to successfully complete such a transaction.  Any acquisition or merger we undertake may result in a potentially dilutive issuance of equity securities, the issuance of debt and incurrence of expenses related to the transaction.

We have limited operating history and we cannot assure you that we will succeed or be profitable.  From March 1, 2005 (inception) through July 31, 2012, we generated revenues of only $34,518.  We are in the development stage, as that term is defined by certain financial accounting standards.  This means that as of July 31, 2012, our planned principal operations had not commenced, as we had devoted substantially all of our efforts to financial planning, raising capital, and developing markets.  We cannot assure you that we will be successful or profitable.

We do not have sufficient working capital to pay our debts or our costs of continuing operations.  We do not currently have sufficient working capital to pay our debts as they become due or our costs of operating our business.  As of July 31, 2012, our working capital deficiency was $773,822.  We are dependent upon additional debt or equity financing to pay our debts and the costs of operation.  If we are unsuccessful in raising additional funds, we may not be able to begin our planned operations or continue as a going concern, and we may have to either liquidate our company or file for bankruptcy protection from our creditors.

We have significant financial obligations pursuant to past employment agreements that we may not be able to pay.  In addition to our debt obligations, we had employment agreements that placed significant accrued salary obligations on us.  Once we have raised sufficient capital to begin operation and begin paying our employees pursuant to the employment agreements, we may not be able to pay or otherwise satisfy the obligations that have accrued.  If we cannot pay the obligations under the employment agreements, we may lose our employees.

Risks Factors Relating To Our Common Stock

Future equity transactions, including exercise of options or warrants, could result in dilution.  In order to raise sufficient capital to implement our planned operations, from time to time, we intend to sell restricted stock, warrants, and convertible debt to investors in private placements.  Because the stock will be restricted, the stock will likely be sold at a greater discount to market prices compared to a public stock offering, and the exercise price of the warrants is likely to be at or even lower than market prices.  These transactions will cause dilution to existing stockholders.  Also, from time to time, options will be issued to officers, directors, or employees, with exercise prices equal to market.  Exercise of in-the-money options and warrants will result in dilution to existing
 
 
5

 
 
stockholders.  The amount of dilution will depend on the spread between the market and exercise price, and the number of shares involved.  In addition, such shares would increase the number of shares in the “public float” and could depress the market price for our common stock.

Our common stock is subject to SEC “Penny Stock” rules.  Since our common stock is a penny stock, as defined in Rule 3a51-1 under the Securities Exchange Act, it will be more difficult for investors to liquidate their investment of our common stock.  Until the trading price of the common stock rises above $5.00 per share, if ever, trading in the common stock is subject to the penny stock rules of the Securities Exchange Act specified in rules 15g-1 through 15g-10.  Those rules require broker-dealers, before effecting transactions in any penny stock, to:

 l
Deliver to the customer, and obtain a written receipt for, a disclosure document;
 l
Disclose certain price information about the stock;
 l
Disclose the amount of compensation received by the broker-dealer or any associated person of the broker-dealer;
 l
Send monthly statements to customers with market and price information about the penny stock; and
 l
In some circumstances, approve the purchaser’s account under certain standards and deliver written statements to the customer with information specified in the rules.

Consequently, the penny stock rules may restrict the ability or willingness of broker-dealers to sell the common stock and may affect the ability of holders to sell their common stock in the secondary market and the price at which such holders can sell any such securities.  These additional procedures could also limit our ability to raise additional capital in the future.

Since our shares are quoted on the OTC Link, trading volumes and prices may be sporadic because it is not an exchange.  Our common shares are currently quoted on the OTC Link.  The trading price of our common shares has been subject to wide fluctuations.  Trading prices of our common shares may fluctuate in response to a number of factors, many of which will be beyond our control.  The stock market has generally experienced extreme price and volume fluctuations that have often been unrelated or disproportionate to the operating performance of companies with limited business operations.  There can be no assurance that trading prices previously experienced by our common shares will be matched or maintained.  Broad market and industry factors may adversely affect the market price of our common shares, regardless of our operating performance.

In the past, following periods of volatility in the market price of a company’s securities, securities class-action litigation has often been instituted.  Such litigation, if instituted, could result in substantial costs for us and a diversion of management’s attention and resources.

We are subject to SEC regulations and changing laws, regulations and standards relating to corporate governance and public disclosure, including the Sarbanes-Oxley Act of 2002, new SEC regulations and other trading market rules, which are creating uncertainty for public companies.  We are committed to maintaining high standards of corporate governance and public disclosure.  As a result, we intend to invest appropriate resources to comply with evolving standards, and this investment may result in increased general and administrative expenses and a diversion of management time and attention from revenue-generating activities to compliance activities.

ITEM 1B.UNRESOLVED STAFF COMMENTS

Not required for smaller reporting companies.

ITEM 2.PROPERTIES

Our principal offices are located at 3801 East Florida Avenue, Suite 400, Denver, Colorado.  We lease these offices pursuant to a month-to-month lease.  The base rent on the lease is $150 per month.

Our legal address for our U.K. subsidiary is that of the accountant and financial firm Wilkins Kennedy, 77-79 High Street, Egham, Surrey TW20 9HY, UK.

 
6

 
ITEM 3.LEGAL PROCEEDINGS

There are no legal proceedings pending against us.  To the best of our knowledge, there are no legal proceedings threatened or contemplated against us.

ITEM 4.MINE SAFETY DISCLOSURES

Not applicable


PART II

ITEM 5.
MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

Market Information

Our common stock is currently quoted in the OTC Link on the OTCQB tier under the symbol “WWSG.”  The following table sets forth the range of high and low bid quotations for each fiscal quarter for the last two completed fiscal years and have been adjusted to reflect the effects of reverse stock splits.  These quotations reflect inter-dealer prices without retail mark-up, mark-down, or commissions and may not necessarily represent actual transactions.

Fiscal Quarter Ending
High Bid
Low Bid
October 31, 2010
$0.16
$0.06
January 31, 2011
$0.24
$0.06
April 30, 2011
$0.15
$0.06
July 31, 2011
$0.14
$0.07
October 31, 2011
$0.15
$0.04
January 31, 2012
$0.05
$0.04
April 30, 2012
$0.05
$0.03
July 31, 2012
$0.04
$0.01

On September 27, 2012, the last trading price for the common stock on the OTC Link was $0.01.

Holders and Dividends

As of September 27, 2012, there were 84 record holders of our common stock.  Since our inception, no cash dividends have been declared on our common stock.

Recent Sales of Unregistered Securities

During the quarter ended July 31, 2012, we issued and sold unregistered securities set forth in the table below.
Date
Persons or Class of Persons
Securities
Consideration
May 2012
1 accredited investor
387,500 shares of common stock
Interest and loan renewal fees valued at $11,625
May 2012
1 consultant
15,000 shares of common stock
Services valued at $450
July 2012
1 consultant
300,000 shares of common stock
Services valued at $12,000

No underwriters were used in the above stock transactions.  We relied upon the exemption from registration contained in Section 4(2) and/or Regulation S as to all of the transactions, as the investors were either deemed to be sophisticated with respect to the investment in the securities due to their financial condition and involvement in our business or were accredited investors.  Additionally, none of these investors were U.S. Persons.  Restrictive legends were placed on the certificates evidencing the securities issued in all of the above transactions.

 
7

 
 
ITEM 6.
SELECTED FINANCIAL DATA

Not required for smaller reporting companies.

ITEM 7.
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion and analysis of our financial condition and plan of operation should be read in conjunction with our Consolidated Financial Statements and related notes appearing elsewhere in this report.

Overview

On July 8, 2005, pursuant to a Share Exchange Agreement with Worldwide Business Solutions Incorporated, a Colorado corporation (“WBSI”), we acquired all of the issued and outstanding capital stock of WBSI, in exchange for 2,573,335 shares of our common stock.  As a result of this share exchange, shareholders of WBSI as a group owned approximately 76.8% of the shares then outstanding, and WBSI became our wholly-owned subsidiary.

For accounting purposes, the acquisition of WBSI has been accounted for as a recapitalization of WBSI.  Since we had only minimal assets and no operations, the recapitalization has been accounted for as the sale of 778,539 shares of WBSI common stock for our net liabilities at the time of the transaction.  Therefore, the historical financial information prior to the date of the recapitalization is the financial information of WBSI.

Effective July 31, 2007, we filed a Certificate of Change Pursuant to NRS 78.209, which decreased the number of our authorized shares of common stock from 100,000,000 to 33,333,333 and reduced the number of common shares issued and outstanding from 17,768,607 to 5,923,106.  All shares and per share amounts in our consolidated financial statements and related notes have been retroactively adjusted to reflect the one-for-three reverse stock split for all periods presented.

On July 31, 2007, we acquired 100% of the issued and outstanding shares of Centric in exchange for 2,250,000 shares of our common stock.  As a result of the acquisition, Centric became our wholly-owned subsidiary and the results of its operations have been included in our consolidated financial statements since the date of acquisition.

We currently devote substantially all of our efforts to financial planning, raising capital and developing markets as we continue to be in the development stage.

Results of Operations

During the years ended July 31, 2012 and 2011, we had no revenue.

Salaries, benefits and payroll taxes totaled $-0- and $107,500 for the year ended July 31, 2012 and July 31, 2011, respectively, as we ceased accruing salary for James Samuels and our former chief financial officer after July 31, 2011.

We incurred non-cash stock-based compensation expense of $61,500 and $-0- during the years ended July 31, 2012 and 2011, respectively, as a result of issuing shares and options to our employees and directors for services.

Professional and consulting fees were $94,423 and $96,292 for the years ended July 31, 2012 and 2011, respectively.

Travel expenses totaled $22,008 and $40,950 for the years ended July 31, 2012 and 2011, respectively, the decline due to a decreased level of activity and a focus on cost control.

 
8

 
Contract labor was $-0- and $75,000 for the years ended July 31, 2012 and 2011, respectively.  The prior chief financial officer had a contract for services of this amount in 2011.

Insurance expenses totaled $-0- and $11,200 for the years ended July 31, 2012 and 2011, respectively, with the insurance program discontinued while the company is in development stage.

For the years ended July 31, 2012 and 2011, we incurred other general and administrative expenses of $4,192 and $4,975, respectively.

Interest expense was $134,918 and $164,426 for the years ended July 31, 2012 and 2011, respectively.

March 1, 2005 to July 31, 2012.  For the period from March 1, 2005 to July 31, 2012, we were engaged primarily in raising capital to implement our business plan.  Accordingly, we incurred expenses for professional and consulting fees, salaries and payroll taxes, travel, and contract labor, resulting in a net loss of $7,676,380 for the period.

Liquidity and Capital Resources

Since our inception through July 31, 2012, we have relied on the sale of equity capital and debt instruments to fund working capital and the costs of developing our business plan.  Net cash provided by financing activities of $2,328,108 offset the $2,199,792 used in operating activities and $123,606 used in investing activities.  For the year ended July 31, 2012, $50,160 provided by financing activities offset $45,616 used in operating activities.

We had deficiency in working capital of $773,822 at July 31, 2012, primarily as a result of accrued salaries and outstanding notes classified as current liabilities as their maturity dates are within one year of the balance sheet date.  Of our current liabilities totaling $782,269, accrued compensation is $410,625.  The officers for whom compensation has been accrued have agreed that this compensation will be paid only if the Company successfully obtains sufficient financing to fund its plan of operation.

During the year ended July 31, 2012, we borrowed $71,160.  During the 2011 fiscal year, we borrowed $21,000.

Going Concern

The report of our independent registered public accounting firm on the financial statements for the year ended July 31, 2012, includes an explanatory paragraph relating to the uncertainty of our ability to continue as a going concern.  We have incurred recurring losses, incurred liabilities in excess of assets over the past year, and have an accumulated deficit of $7,676,380.  Based upon current operating levels, we will be required to obtain additional capital or reconfigure our operations in order to sustain our operations through July 31, 2013.

Contractual Obligations

We lease office space on a month-to-month basis at a rate of $150 per month.  We have no other contractual commitments.

Plan of Operations

As of the date hereof, we do not have any plans for business operations, merger or acquisition, other than the proposed business combination transaction with Euzkadi.  We cannot assure you that this transaction will be completed.

We must raise additional capital to support our ongoing existence while we search for other merger opportunities.  We cannot assure you that we will be able to complete additional financings successfully.

 
9

 
Significant Accounting Policies and Estimates

Our discussion and analysis of our financial condition and results of operations are based upon our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America.  The preparation of these consolidated financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosures of contingent assets and liabilities.  On an ongoing basis, we evaluate our estimates, including those related to the valuation of accounts receivable and inventories, the impairment of long-lived assets, any potential losses from pending litigation and deferred tax assets or liabilities.  We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources.  Actual results may differ from these estimates under different assumptions or conditions; however, we believe that our estimates, including those for the above-described items, are reasonable.

Development Stage.  We are in the development stage in accordance with Statements of Financial Accounting Standards (SFAS) No. 7 “Accounting and Reporting by Development Stage Enterprises.”  As of July 31, 2012, we had devoted substantially all of our efforts to financial planning, raising capital and developing markets.

Stock-based Compensation.  The Company accounts for all stock-based payments to employees and non-employees under ASC 718 “Stock Compensation,” using the fair value based method. Under the fair value method, stock-based payments are measured at the fair value of the consideration received, or the fair value of the equity instruments issued, or liabilities incurred, whichever is more reliably measurable. The cost of stock-based payments to non-employees that are fully vested and non-forfeitable at the grant date is measured and recognized at that date.

Loss per common share.  We report net loss per share using a dual presentation of basic and diluted loss per share.  Diluted net loss per share utilizes the average market price per share when applying the treasury stock method in determining common stock equivalents.  As of July 31, 2012, after recognition of the one-for-three reverse stock split, there were 3,508,328 vested common stock options outstanding, which were excluded from the calculation of net loss per share-diluted because they were antidilutive.

New accounting pronouncements

Note 1 to the consolidated financial statements includes a complete description of new accounting pronouncements applicable to our Company.

Off Balance Sheet Arrangements

We do not have any material off balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources.

ITEM 7A.
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Not applicable.


 
10

 

ITEM 8.FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

WORLDWIDE STRATEGIES INCORPORATED
(A Development Stage Company)
Index to Consolidated Financial Statements

   
Page
     
Report of Independent Registered Public Accounting Firm
12
     
Consolidated Balance Sheet
13
     
Consolidated Statements of Operations
14
     
Consolidated Statements of Changes in Shareholders’ Deficit
15
     
Consolidated Statements of Cash Flows
17
     
Notes to Consolidated Financial Statements
18


 
11

 

HAMILTON PC


2121 S. Oneida St., Suite 312
Denver, CO  80224
P: (303) 548-8072
F: (888) 466-4216
ed@hamiltonpccpa.com


REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM


The Board of Directors and Stockholders
Worldwide Strategies Incorporated

We have audited the accompanying consolidated balance sheets of Worldwide Strategies Incorporated, as of July 31, 2012 and 2011, and the related statements of operations, stockholders’ equity (deficit) and cash flows for the years in the periods ended July 31, 2012 and 2011. These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these financial statements based on our audits.

We conducted our audit in accordance with standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audit included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion.

In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of Worldwide Strategies Incorporated as of July 31, 2012 and 2011, and the results of its operations and its cash flows for the years in the period ended July 31, 2012 and 2011, in conformity with U.S. generally accepted accounting principles.

The accompanying financial statements have been prepared assuming that Worldwide Strategies Incorporated will continue as a going concern. As discussed in Note 1 to the financial statements, Worldwide Strategies Incorporated suffered recurring losses from operations which raises substantial doubt about its ability to continue as a going concern. Management's plans regarding those matters also are described in Note 1. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Hamilton, PC

/s/ Hamilton, PC

Denver, Colorado
September 29, 2012


 
12

 

WORLDWIDE STRATEGIES INCORPORATED
(A Development Stage Company)
Consolidated Balance Sheet
July 31, 2012

   
July 31,
 
   
2012
 
   
 
 
Assets
     
Current Assets:
     
Cash
  $ 4,710  
  Prepaid expenses
    3,738  
         
Total current assets
    8,447  
         
Office equipment, net of accumulated depreciation of $22,623
     
Deposits
    150  
         
Total assets
  $ 8,597  
         
         
Liabilities and Shareholders’ Deficit
       
Current Liabilities:
       
Accounts and notes payable:
       
Accounts payable
  $ 80,464  
Accounts payable, related party(Note 2)
    3,900  
Accrued compensation(Note 3)
    410,625  
Accrued liabilities
    15,597  
Accrued liabilities, related party (Note 4)
    100,523  
Notes payable (Note 5)
    171,161  
         
Total current liabilities
    782,269  
         
Shareholders’ deficit (Note 6):
       
Preferred stock, $.001 par value; 25,000,000 shares authorized,
 
1,491,743 shares issued and outstanding
    1,492  
Common stock, $.001 par value, 33,333,333 shares authorized
 
16,870,234 and 14,241,234 shares issued and outstanding respectively.
    16,871  
 Additional paid-in capital
    6,884,345  
 Deficit accumulated during development stage
    (7,676,380 )
         
Total shareholders’ deficit
    (773,672 )
         
Total liabilities and shareholders' deficit
  $ 8,597  

See accompanying notes to the consolidated financial statements.

 
13

 

WORLDWIDE STRATEGIES INCORPORATED
(A Development Stage Company)
Consolidated Statements of Operations

 
               
March 1, 2005
 
               
(Inception)
 
   
For the Year Ended
   
Through
 
   
July 31,
   
July 31,
 
   
2012
   
2011
   
2012
 
                   
Sales
  $     $     $ 34,518  
Cost of sales
                30,568  
                         
                  3,950  
                         
Operating expenses:
                       
  Salaries, benefits and payroll taxes
          107,500       1,108,375  
  Stock based compensation
    61,500             3,462,703  
  Professional and consulting fees
    94,423       96,292       1,038,540  
Travel
    22,008       40,950       310,330  
  Contract labor
          75,000       558,000  
    Insurance
          11,200       253,506  
  Depreciation
          51       140,278  
  Loss on failed acquisition
                181,016  
  Other general and administrative expenses
    4,192       4,975       215,955  
                         
Total operating expenses
    182,124       335,968       7,268,704  
Loss from operations
    (182,124 )     (335,968 )     (7,264,754 )
                         
Other expense:
                       
Interest expense
    (134,918 )     (164,426 )     (411,626 )
                         
Loss before income taxes
    (317,042 )     (500,394 )     (7,676,380 )
                         
Income tax provision (Note 7)
                 
                         
Net loss
  $ (317,042 )   $ (500,394 )   $ (7,676,380 )
                         
Basic and diluted loss per share
  $ (0.013 )   $ (0.022 )        
                         
Basic and diluted weighted average
                       
common shares outstanding
    24,985,016       22,257,993          


See accompanying notes to the consolidated financial statements.

 
14

 

WORLDWIDE STRATEGIES INCORPORATED
(A Development Stage Company)
Consolidated Statements of Changes in Shareholders’ Deficit


                             
 
Deficit
   
                                 Accumulated    
                             Additional    During    
                 Preferred Stock  Common Stock  Paid-In    Development    
               
Shares
 
Par Value
Shares
 
Par Value
Capital
 
Stage
 
Total
Balance at March 1, 2005 (inception)
—    
$
—    
—    
$
—    
$
—    
$
—    
$
—    
                                       
March 1, 2005, sale of common stock
                 
 
to founders
—    
 
—    
1,733,402  
 
1,733  
 
3,467  
 
—    
 
5,200  
April though June 2005, sale of common
                 
 
stock in private offering at $.75 per
                 
 
share, net of $65,089 of offering
                 
 
costs
       
—    
 
—    
840,033  
 
840  
 
564,071  
 
—    
 
559,911  
July 2005, stock issued in recapitalization
                 
 
with Barnett Energy Corp.
—    
 
—    
778,539  
 
779  
 
(828)
 
—    
 
(49)
                                       
July 8, 2005, following recapitalization
—    
 
—    
3,351,974  
 
3,352  
 
566,710  
 
—    
 
565,062  
                                       
July 2005, sale of common stock in
                 
 
private offering at $.75 per share,
                 
 
net of $25,000 of offering costs
—    
 
—    
333,347  
 
333  
 
224,667  
 
—    
 
225,000  
Net loss, March 1, 2005 (Inception)
                 
 
through July 31, 2005
—    
 
—    
—    
 
—    
 
—    
 
(323,298)
 
(323,298)
Balance at July 31, 2005
—    
 
—    
3,685,321  
 
3,685  
 
791,377  
 
(323,298)
 
466,764  
                                       
August 2005, collection of common stock
                 
 
subscriptions
     
—    
 
—    
 
—    
 
—    
 
5,000  
August 2005, sale of common stock in
                 
 
private offering at $.75 per share, net
                 
 
of $49,500 of offering costs
—    
 
—    
660,026  
 
660  
 
444,840  
 
—    
 
445,500  
July 2006, sale of common stock in
                 
 
private offering at $.15 per share, net
                 
 
of $9,500 of offering costs
—    
 
—    
633,359  
 
634  
 
84,866  
 
—    
 
85,500  
Stock options issued in exchange for
                 
 
accrued compensation and
                     
 
expenses
 
—    
 
—    
—    
 
—    
 
2,498,113  
 
—    
 
2,498,113  
Stock warrants issued in exchange for
                 
 
the Cascade Letter of Intent
                     
 
termination
—    
 
—    
—    
 
—    
 
49,500  
 
—    
 
49,500  
Net loss for the year ended July 31, 2006
—    
 
—    
—    
 
—    
 
—    
 
(3,659,020)
 
(3,659,020)
Balance at July 31, 2006
—    
 
—    
4,978,706  
 
4,979  
 
3,868,696  
 
(3,982,318)
 
(108,643)
                                       
August 2006, sale of common stock in
                 
 
private offering at $.15 per share, net
                 
 
of $10,750 of offering costs
—    
 
—    
750,030  
 
750  
 
100,999  
 
—    
 
101,749  
Common stock  issued in exchange for
                 
 
 commission and interest
—    
 
—    
73,531  
 
74  
 
17,651  
 
—    
 
17,725  
Common stock  issued in exchange for
                 
 
 consulting fees
—    
 
—    
120,839  
 
121  
 
27,879  
 
—    
 
28,000  
Stock options vesting in period
—    
 
—    
—    
 
—    
 
583,990  
 
—    
 
583,990  
Common stock  issued in exchange for all
                 
 
the outstanding stock of Centric Rx Inc
—    
 
—    
2,250,000  
 
2,250  
 
39,423  
 
—    
 
41,673  
Net loss for the year ended July 31, 2007
—    
 
—    
—    
 
—    
 
—    
 
(1,226,319)
 
(1,226,319)
Balance at July 31, 2007
—    
 
—    
8,173,106  
 
8,174  
 
4,638,638  
 
(5,208,637)
 
(561,825)
                                       
August 2007, common stock issued
                 
 
at $.15 to pay promissory note
—    
 
—    
500,000  
 
500  
 
74,500  
 
—    
 
75,000  
Common stock  issued in exchange for
                 
 
 interest
   
—    
 
—    
160,105  
 
160  
 
12,890  
 
—    
 
13,050  
Common stock  issued in exchange for
                 
 
unpaid effort
—    
 
—    
450,000  
 
450  
 
19,800  
 
—    
 
20,250  
Capital contribution
—    
 
—    
—    
 
—    
 
50,000  
 
—    
 
50,000  
Stock options vesting in period
—    
 
—    
—    
 
—    
 
38,350  
 
—    
 
38,350  
Expenses paid-capital contribution
—    
 
—    
—    
 
—    
 
1,797  
 
—    
 
1,797  
Net loss for the year ended July 31, 2008
—    
 
—    
—    
 
—    
 
 
 
(846,213)
 
(846,213)
Balance at July 31, 2008
—    
 
—    
9,283,211  
 
9,284  
 
4,835,975  
 
(6,054,850)
 
(1,209,591)

See accompanying notes to the consolidated financial statements.
 
 
15

 
WORLDWIDE STRATEGIES INCORPORATED
(A Development Stage Company)
Consolidated Statements of Changes in Shareholders’ Deficit


                             
Additional
Deficit
   
                                 Accumulated    
                             Additional    During    
                 Preferred Stock  Common Stock  Paid-In    Development    
               
Shares
 
Par Value
Shares
 
Par Value
Capital
 
Stage
 
Total
                                       
Common stock  issued in exchange for
                 
 
interest
   
—    
 
—    
18,023  
 
18  
 
2,451  
 
—    
 
2,469  
Deposit on proposed acquisition
—    
 
—    
—    
 
—    
 
25,000  
 
—    
 
25,000  
Expenses paid-capital contribution
—    
 
—    
—    
 
—    
 
395  
 
—    
 
395  
Common stock  issued in exchange for
                 
 
unpaid effort
—    
 
—    
2,825,000  
 
2,825  
 
169,925  
 
—    
 
172,750  
Common stock issued in exchange for
                 
 
interest
   
—    
 
—    
100,000  
 
100  
 
6,900  
 
—    
 
7,000  
Stock options vesting in period
—    
 
—    
—    
 
—    
 
12,000  
 
—    
 
12,000  
Preferred stock issued in exchange for
                 
 
convertible promissory notes
1,362,643  
 
1,363  
—    
 
—    
 
679,958  
 
—    
 
681,321  
Preferred stock issued for cash
16,000  
 
16  
—    
 
—    
 
7,984  
 
—    
 
8,000  
Accrued salaries forgiven
—    
 
—    
—    
 
—    
 
642,537  
 
—    
 
642,537  
Net loss for the year ended July 31, 2009
—    
 
—    
—    
 
—    
 
—    
 
(464,456)
 
(464,456)
Balance at July 31, 2009
1,378,643  
 
1,379  
12,226,234  
 
12,227  
 
6,383,125  
 
(6,519,306)
 
(122,575)
                                       
Common stock  issued in exchange for
                 
 
 consulting fees
     
270,000  
 
270  
 
20,830  
     
21,100  
Deposit on proposed acquisition
           
2,240  
     
2,240  
Preferred stock issued in exchange for
                 
 
convertible promissory notes
42,400  
 
42  
       
21,158  
     
21,200  
Preferred stock issued for cash
3,200  
 
3  
       
1,597  
     
1,600  
Preferred stock  issued in exchange for
                 
 
unpaid effort
67,500  
 
68  
       
33,682  
     
33,750  
Net loss for the year ended July 31, 2010                    (339,638)   (339,638) 
Balance at July 31, 2010
1,491,743  
 
1,492  
12,496,234  
 
12,497  
 
6,462,632  
 
(6,858,944)
 
(382,323)
                                       
Common stock  issued in exchange for
                 
 
interest (Note 6)
     
1,395,000  
 
1,395  
 
186,542  
     
187,937  
Common stock  issued in exchange for
                 
 
 consulting fees (Note 6)
   
350,000  
 
350  
 
47,150  
     
47,500  
Net loss for the year ended July 31, 2011                   (500,394)   (500,394)
Balance at July 31, 2011
1,491,743  
$
1,492  
14,241,234  
$
14,242  
$
6,696,324  
$
(7,359,338)
$
(647,280)
                                       
Common stock  issued in exchange for
                 
 
interest
         
1,395,000  
 
1,395  
 
99,355  
     
100,750  
Common stock  issued in exchange for
                 
 
board member services
   
300,000  
 
300  
 
35,700  
     
36,000  
Common stock issued in exchange for
                 
 
CFO compensation
     
300,000  
 
300  
 
13,200  
     
13,500  
Common stock issued for consulting
                 
 
services
         
634,000  
 
634  
 
27,766  
     
28,400  
Common stock options issued in exchange
                 
 
for CFO Compensation
           
12,000  
     
12,000  
                                       
Net loss for the year ended July 31, 2012
                 
(317,042)
 
(317,042)
                                       
Balance at July 31, 2012
1,491,743  
$
1,492  
16,870,234  
$
16,871  
$
6,884,345  
$
(7,676,380)
$
(773,672)
 
See accompanying notes to the consolidated financial statements.
 
 
16

 
WORLDWIDE STRATEGIES INCORPORATED
(A Development Stage Company)
Consolidated Statements of Cash Flows

               
March 1, 2005
 
               
(Inception)
 
   
For The Year Ended
   
Through
 
   
July 31,
   
July 31,
 
   
2012
   
2011
   
2012
 
                   
Cash flows from operating activities:
                 
Net loss
  $ (317,042 )   $ (500,394 )   $ (7,676,380 )
  Adjustments to reconcile net loss to net cash
                 
 used in operating activities:
                       
Depreciation
          51       140,278  
Loss on failed acquisition
                150,000  
Stock based compensation (Notes 4 and 5)
    61,500             3,462,703  
Consulting expense paid in common stock
    28,400       47,500       125,000  
Consulting expenses paid in perferred stock
                7,500  
Expenses paid with capital contribution
                93,042  
Interest expense paid in common stock(Note 5)
    100,751       187,937       322,432  
Interest expense paid in preferred stock(Note 4 and 5 )
                4,745  
Interest expense capitalized as principal
    260             54,293  
Net liabilities acquired in Barnett recapitalization
                49  
Changes in current assets and liabilities:
                       
Receivables, prepaid expenses and other
                 
current assets
    24,430       (16,613 )     (53,985 )
Accounts payable
    23,338       22,929       84,364  
Accrued liabilities
    32,748       228,042       1,086,167  
Net cash used in
                       
operating activities
  $ (45,616 )   $ (30,548 )   $ (2,199,792 )
                         
Cash flows from investing activities:
         
`
         
Cash acquired in Centric acquisition
                6  
Purchases of equipment
                (23,612 )
Deposit paid on Cascade acquisition
                (100,000 )
Net cash used in
                       
investing activities
                (123,606 )
                         
Cash flows from financing activities:
                       
Proceeds from sale of preferred stock
                9,600  
Proceeds from sale of common stock
                1,587,706  
Deposit on proposed acquisition
                77,240  
Payments for offering costs
                (150,339 )
Proceeds from notes payable, related party
    9,174       4,000       299,475  
Proceeds from notes payable
    61,986       17,000       546,471  
Payment of notes payable
    (21,000 )     (10,523 )     (42,045 )
Net cash provided by
                       
financing activities
    50,160       10,477       2,328,108  
                         
Net change in cash.
    4,544       (20,071 )     4,710  
                         
Cash, beginning of period
    166       20,237        
                         
Cash, end of period
  $ 4,710     $ 166     $ 4,710  
                         
Supplemental disclosure of cash flow information:
                 
Cash paid during the period for:
                       
                Income taxes
  $     $     $  
Interest
  $     $     $ 7,518  
Non-cash investing/financing activities
                       
Preferred stock issued to repay notes
  $     $     $ 652,274  
Common stock issued to repay loan
  $     $     $ 75,000  
Common stock issued to acquire Centric
  $     $     $ 41,673  
Offering costs exchanged for stock
  $     $     $ 6,500  
 
See accompanying notes to the consolidated financial statements.

 
17

 

WORLDWIDE STRATEGIES INCORPORATED
(A Development Stage Company)
Notes to Financial Statements
 
(1)           Organization, Basis of Presentation, and Summary of Significant Accounting Policies

Organization and Basis of Presentation

Worldwide Strategies Incorporated (the “Company”) was originally incorporated in the state of Nevada on April 6, 1998.  On March 1, 2005, Worldwide Business Solutions Incorporated (“WBSI”) was incorporated in the State of Colorado.  On July 8, 2005, the Company acquired all the shares of WBSI for 76.8% of the Company’s outstanding stock.  The acquisition of WBSI has been accounted for as a recapitalization of WBSI.  Therefore the historical information prior to the date of recapitalization is the financial information of WBSI.

Effective July 31, 2007 the Company filed a Certificate of Change Pursuant to NRS 78.209, which decreased the number of its authorized shares of common stock from 100,000,000 to 33,333,333 and reduced the number of common shares issued and outstanding from 17,768,607 to 5,923,106.

All shares and per share amounts in these Consolidated Financial Statements and related notes have been retroactively adjusted to reflect the reverse stock split for all periods presented.

On July 31, 2007, the Company acquired 100% of the issued and outstanding shares of Centric Rx, Inc., (“Centric”) in exchange for 2,250,000 shares of the Company’s common stock.  As a result of the acquisition, Centric became a wholly owned subsidiary of the Company and the results of its operation have been included in the Company’s consolidated financial statements since the date of acquisition.

Development Stage

The Company and its subsidiaries are in the development stage in accordance with Statements of Financial Accounting Standards (SFAS) No. 7 “Accounting and Reporting by Development Stage Enterprises.”  As of July 31, 2012, the Company has devoted substantially all of its efforts to financial planning, raising capital and developing markets.

Going Concern

The accompanying financial statements have been prepared in conformity with generally accepted accounting principles in the United States, which contemplate continuation of the Company as a going concern.  However, the Company experienced net losses of $317,042, $500,394, and $7,676,380 for the years ended July 31, 2012 and 2011 and for the period from March 1, 2005 (inception) through July 31, 2012, respectively.  In addition, the Company has incurred liabilities in excess of assets over the past year and, as of July 31, 2012, and has an accumulated deficit of $7,676,380. These matters, among others, raise substantial doubt about its ability to continue as a going concern.
 
In view of the matters described above, recoverability of a major portion of the recorded asset amounts shown in the accompanying balance sheet is dependent upon the Company’s ability to generate sufficient sales volume to cover its operating expenses and to raise sufficient capital to meet its payment obligations.  Historically, management has been able to raise additional capital. During the year ended July 31, 2012, the Company issued convertible promissory notes, in exchange for $50,160.

The financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts, or amounts and classification of liabilities that might be necessary should the Company be unable to continue in existence.

Principles of Consolidation

The accompanying Consolidated Financial Statements include the Company’s accounts and those of its wholly owned subsidiaries.  All significant intercompany transactions and balances have been eliminated in consolidation.

 
18

 
WORLDWIDE STRATEGIES INCORPORATED
(A Development Stage Company)
Notes to Financial Statements
 
Use of Estimates

The preparation of financial statements in accordance with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.

Cash and Cash Equivalents

The Company considers all highly liquid debt instruments with original maturities of three months or less when acquired to be cash equivalents.  The Company had no cash equivalents at July 31, 2012.

Financial Instruments

The carrying amounts of cash and current liabilities approximate fair value due to the short-term maturity of the instruments.

Property and Equipment

Property and equipment are stated at cost.  Depreciation is calculated using the straight-line method over the estimated useful lives of the related assets, currently ranging from three to five years.  Expenditures for additions and improvements are capitalized, while repairs and maintenance costs are expensed as incurred.  The cost and related accumulated depreciation of property and equipment sold or otherwise disposed of are removed from the accounts and any gain or loss is recorded in the year of disposal.
 
   
July 31,
 
   
2012
   
2011
 
Office equipment
 
$
10,600
   
$
10,600
 
Software
   
12,023
     
12,023
 
     
22,623
     
22,623
 
Accumulated depreciation
   
22,623
     
22,623
 
Property and equipment - net
 
$
0
   
$
0
 

Depreciation expense for the years ended July 31, 2012 and 2011 and for the period from March 1, 2005 (inception) through July 31, 2012 totaled $-0-, $51, and $140,278, respectively.

Impairment of Long-Lived Assets

The Company has adopted ASC 360, “Accounting for the Impairment or Disposal of Long-Lived Assets,” which requires that long-lived assets to be held be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.  ASC 360 establishes a single auditing model for long-lived assets to be disposed of by sale.

Loss per Common Share

The Company reports net loss per share using a dual presentation of basic and diluted loss per share. Basic loss per share includes the impact of issuing 1,491,743 shares of Series A Convertible Preferred Stock and excludes the impact of other contingently exercisable common stock equivalents. Diluted net loss per share utilizes the average market price per share when applying the treasury stock method in determining common stock equivalents. As of July 31, 2012, there were 3,508,328 vested common stock options outstanding, which were excluded from the calculation of net loss per share-diluted because they are antidilutive.

 
19

 
WORLDWIDE STRATEGIES INCORPORATED
(A Development Stage Company)
Notes to Financial Statements
 
Stock-based Compensation

The Company accounts for all stock-based payments to employees and non-employees under ASC 718 “Stock Compensation,” using the fair value based method. Under the fair value method, stock-based payments are measured at the fair value of the consideration received, or the fair value of the equity instruments issued, or liabilities incurred, whichever is more reliably measurable. The cost of stock-based payments to non-employees that are fully vested and non-forfeitable at the grant date is measured and recognized at that date.

Fiscal Year-end

The Company’s year-end is July 31.

New Accounting Pronouncements

In January 2010, the FASB issued ASU 2010-06, “Improving Disclosures about Fair Value measurements,” which amends ASC 820, “Fair Value Measures and Disclosures.” ASU 2010-06 requires disclosure of transfers into and out of Level 1 and Level 2 fair value measurements, and also requires more detailed disclosure about the activity within Level 3 fair value measurements. The changes to the ASC as a result of this update are effective for annual and interim reporting periods beginning after December 15, 2009, except for requirements related to Level 3 disclosures, which are effective for annual and interim reporting periods beginning after December 15, 2010. This guidance requires new disclosures only, and had no impact on our financial statements. In February 2010, the FASB issued ASU 2010-09, “Subsequent Events (Topic 855).” This update provides amendments to Subtopic 855-10-50-4 and related guidance within U.S. GAAP to clarify that an SEC registrant is not required to disclose the date through which subsequent events have been evaluated. This change alleviates potential conflicts between Subtopic 855-10 and the SEC’s requirements. The Company has adopted this standard and it had no impact on this financial statements.
 
In December 2010, the FASB issued ASU 2010-29, which contains updated accounting guidance to clarify the acquisition date that should be used for reporting pro forma financial information when comparative financial statements are issued. This update requires that a company should disclose revenue and earnings of the combined entity as though the business combination(s) that occurred during the current year had occurred as of the beginning of the comparable prior annual reporting period only. This update also requires disclosure of the nature and amount of material, nonrecurring pro forma adjustments. The provisions of this update, which are to be applied prospectively, are effective for business combinations for which the acquisition date is on or after the beginning of the first annual reporting period beginning on or after December 15, 2010, with early adoption permitted. The impact of this update on the Company’s financial statements will depend on the size and nature of future business combinations.
 
(2)           Accounts payable related parties

At July 31, 2012, the Company was indebted to related parties for expenses incurred on behalf of the Company totaling $3,900.

(3)           Accrued compensation

At July 31, 2012 and 2011, accrued compensation totaled $410,625. The accrued compensation will only be paid if the Company successfully obtains sufficient financing to fund its plan of operation.
 
 
20

 
WORLDWIDE STRATEGIES INCORPORATED
(A Development Stage Company)
Notes to Financial Statements

(4)           Related party transactions

Accrued liabilities

During the year the CEO paid various liabilities of the Company personally that were not reimbursed. This accrual, totaling $100,044 including amounts accrued in prior periods, will be repaid when the Company has sufficient working capital. An additional amount of $479 represents accrued interest on notes payable to related parties.

Notes payable

During November 2011, the Company issued convertible promissory notes to two related parties totaling $4,173 of principal to replace similar notes issued May 2011. The notes, originally due April 30, 2012 and extended to October 31, 2012, bear interest at 10% and the principal and accrued interest is convertible into common shares at $.07 per share upon the election of the holder. Interest expense for these notes was $312 for the year ended July 31, 2012.

During April 2012, the Company issued a convertible promissory note to a related party for $5,000 of principal. The note, originally due September 30, 2012 and extended to March 31, 2013, bears interest at 10% and the principal and accrued interest is convertible into common shares at $.04 per share upon the election of the holder. Interest expense for this note was $167 for the year ended July 31, 2012.
 
Preferred stock

In December 2008, outstanding notes, including accrued interest, which was capitalized, totaling $322,981 were repaid with the issuance of 645,962 shares of preferred stock. An additional note in the amount of $10,000 was issued to the CEO for cash in April 2009. The note, including $210 in accrued interest, was repaid by issuing 20,420 shares of preferred stock in July 2009.

In May 2010, five directors and two officers were each issued 7,500 preferred shares totaling 52,500 shares in exchange for uncompensated services. This amount ($26,250) is reflected in the accompanying financial statements as stock based compensation.

Common stock

On March 1, 2005, the Company sold 1,733,402 shares of its common stock to its officers, directors and other founders for $5,200, or $.003 per share.  In connection with the stock sales, the Company issued one warrant for each common share purchased.  The warrants allowed the holder to purchase one share of common stock at a price of $.75 per share.  The warrants expired on April 30, 2010.

In January 2008, the Company issued 350,000 shares of the Company’s common stock at $.045 to two officers and five directors as compensation for unpaid services.  The shares were valued based on their fair value when the share issuance was authorized.

In December 2008, the Company issued a total of 425,000 shares of the Company’s common stock in exchange for uncompensated services provided to the Company by two officers and five directors.  The shares were valued at $.03 per share based on the fair value of the shares in the month they were issued. This amount ($12,750) is reflected in the accompanying financial statements as stock based compensation.

In April 2009, the Company issued 2,200,000 shares of the Company’s common stock in exchange for uncompensated services, provided to the Company by two officers, valued at $154,000. The shares were valued at $.07 per share based on the fair value on the date of grant and are reflected in the accompanying financial statements as stock based compensation.


 
21

 
WORLDWIDE STRATEGIES INCORPORATED
(A Development Stage Company)
Notes to Financial Statements


In August 2011, the Company issued 300,000 shares of the Company’s common stock in exchange for uncompensated services provided to the Company by four directors.  The shares were valued at $.12 per share based on the fair value of the shares in the month they were issued. This amount ($36,000) is reflected in the accompanying financial statements as stock based compensation.

In December 2011, the Company issued 150,000 shares of the Company’s common stock in exchange for uncompensated services provided to the company by the VP Finance & CFO.  The shares were valued at $.04 per share based on the fair value of the shares in the month they were issued. This amount ($6,000) is reflected in the accompanying financial statements as stock based compensation.

In March 2012, the Company issued 150,000 shares of the Company’s common stock in exchange for uncompensated services provided to the company by the VP Finance & CFO.  The shares were valued at $.05 per share based on the fair value of the shares in the month they were issued. This amount ($7,500) is reflected in the accompanying financial statements as stock based compensation.

(5)           Notes payable

During November 2009, the Company issued a convertible promissory note to an unrelated third party in exchange for $25,000. The note bears interest at 8% and the principal and accrued interest is convertible, at the option of the note-holder, into non-restricted common stock in an amount equal to the total sum due, based on a mutually agreed discount (not to exceed 50%) to the then market price.  The note holder extended the original due date from May 31, 2010 to December 31, 2010, extended again to July 31, 2011, extended again to June 30, 2012 and extended again to May 31, 2013. Interest expense for this note payable was $2,000 and $2,150 for the years ended July 31, 2012 and 2011, respectively.

During February 2010, the Company issued a convertible promissory note to an unrelated third party in exchange for $25,000. The note bears interest at 8% and the principal and accrued interest is convertible, at the option of the note-holder, into non-restricted common stock in an amount equal to the total sum due, based on a mutually agreed discount (not to exceed 50%) to the then market price. The note holder extended the original due date from July 31, 2010 to December 31, 2010, extended again to July 31, 2011, extended again to June 30, 2012 and extended again to May 31, 2013. Interest expense for this note payable was $2,000 and $2,000 for the years ended July 31, 2012 and 2011, respectively.

During May 2010, the Company issued a convertible promissory note to an unrelated third party in exchange for $50,000. The note bears interest at 9% and the principal and accrued interest is convertible into common shares at $.04 per share upon the election of the holder. The note holder extended the due date from September 23, 2010 to January 21, 2011, to May 21, 2011, to September 18, 2011, to January 16, 2012, to May 15, 2012 and to September 12, 2012. Interest expense, including the premium cost on shares issued for the renewal period, for this note payable was $106,092 and $149,724 for the years ended July 31, 2012 and 2011, respectively.

During December 2010, the Company issued a convertible promissory note to an unrelated third party in exchange for $15,000. The note bears interest at 9% and the principal and accrued interest is convertible into common shares at $.04 per share upon the election of the holder. The note holder extended the due date from April 2, 2011, to July 31, 2011, to November 28, 2011, to March 27, 2012, to July 25, 2012 and to November 22, 2012. Interest expense, including the premium cost on shares issued for the renewal period, for this note payable was $19,149 and $10,088 for the years ended July 31, 2012 and 2011, respectively.

During October 2011, the Company issued a convertible promissory note to an unrelated party in exchange for $15,000. The note, due April 25, 2012 and extended to October 25, 2012, bears interest at 10% and the principal and accrued interest is convertible into common shares at $.07 per share upon the election of the holder. Interest expense for this note was $1,150 for the year ended July 31, 2012.


 
22

 
WORLDWIDE STRATEGIES INCORPORATED
(A Development Stage Company)
Notes to Financial Statements


During November 2011, the Company issued a convertible promissory note to an unrelated party in exchange for $2,087 of principal and accrued interest on a due promissory note. The note, due April 30, 2012 and extended to October 31, 2012, bears interest at 10% and the principal and accrued interest is convertible into common shares at $.07 per share upon the election of the holder. Interest expense for this note was $156 for the year ended July 31, 2012.

During March 2012, the Company issued a convertible promissory note to an unrelated party to replace a note due, including accrued interest, of $15,750.  The note, due August 31, 2012 and extended to February 28, 2013, bears interest at 10% and the principal and accrued interest is convertible into common shares at $.07 per share upon the election of the holder.  Interest expense for this note was $656 for the year ended July 31, 2012.

During March 2012, the Company issued a convertible promissory note to an unrelated party in exchange for $2,150.  The note, due September 11, 2012, bears interest at 10% and the principal and accrued interest is convertible into common shares at $.07 per share upon the election of the holder.  Interest expense for this note was $84 for the year ended July 31, 2012.

During April 2012, the Company issued convertible promissory notes to four unrelated parties in exchange for a total of $12,000.  The notes, due September 30, 2012, bear interest at 10% and the principal and accrued interest is convertible into common shares at $.04 per share upon the election of the holder of each note.  Interest expense for these notes was $400 for the year ended July 31, 2012.

(6)           Shareholders’ Equity

Preferred stock

The Company is authorized to issue 25,000,000 shares of $.001 par value preferred stock. The Company’s Board of Directors may divide and issue the preferred shares in series. Each Series, when issued, shall be designated to distinguish them from the shares of all other series. The relative rights and preferences of these series include preference of dividends, redemption terms and conditions, amount payable upon shares of voluntary or involuntary liquidation, terms and condition of conversion as well as voting powers.
In December 2008, the Company designated 5,000,000 shares of preferred stock as Series A Convertible Preferred Stock (”Series A”). Each share of Series A is convertible into 6.25 shares of common stock at the election of the holder. Each Series A share is entitled to 6.25 votes in any vote of the common stock holders. Series A shares are redeemable by the Company at $.50 per share with 15 days written notice. Series A shares are entitled to a 5% dividend preference and a participation interest in the remaining 95% dividend.
Effective January 31, 2009, the Company issued 658,589 Series A shares at $.50 in full settlement of notes payable and accrued interest in the amount of $329,294.

Also effective January 31, 2009, an additional 16,000 Series A shares were issued for $8,000 in cash.

In July 2009, the Company issued 37,672 Series A shares at $.50 in full settlement of notes payable and accrued interest in the amount of $18,836.
 
In May 2010, the Company issued 3,200 preferred shares at $.50 for cash in the amount of $1,600.

In May 2010, a consultant was issued 15,000 preferred shares in exchange for consulting services. This amount ($7,500) is reflected in the accompanying financial statements as professional and consulting fees.

In June 2010, an outstanding note, including accrued interest, which was capitalized, totaling $21,200 was repaid with the issuance of 42,400 shares of preferred stock. 
 
 
23

 
WORLDWIDE STRATEGIES INCORPORATED
(A Development Stage Company)
Notes to Financial Statements

Common stock

From April through June 2005, the Company conducted a private placement offering whereby it sold 840,033 units at a price of $.75 per unit.  Each unit consisted of one share of the Company’s common stock and one five-year warrant to purchase another share of common stock at $.75 per share.  The Company received net proceeds of $559,911, after deducting offering costs of $65,089.  The offering was made in reliance on exemptions from registration contained in Section 4(2) of the Securities Act of 1933, as amended, and Rule 506 of Regulation D promulgated thereunder.

In July 2005, the Company conducted a private placement offering whereby it sold 333,347 units at a price of $.75 per unit.  Each unit consisted of one share of the Company’s common stock and one five-year warrant to purchase another share of common stock at $.75 per share.  The Company received net proceeds of $225,000, after deducting offering costs of $25,000.  The offering was made in reliance on exemptions from registration contained in Section 4(2) of the Securities Act of 1933, as amended, and Rule 506 of Regulation D promulgated thereunder.

In August 2005, the Company conducted a private placement offering whereby it sold 660,026 units at a price of $.75 per unit.  Each unit consisted of one share of the Company’s common stock and one five-year warrant to purchase another share of common stock at $.75 per share.  The Company received net proceeds of $445,500, after deducting offering costs of $49,500.  The offering was made in reliance on exemptions from registration contained in Section 4(2) of the Securities Act of 1933, as amended, and Rule 506 of Regulation D promulgated thereunder.

In July 2006, the Company conducted a private placement offering whereby it sold 633,359 units at a price of $.15 per unit. Each unit consisted of one share of the Company’s common stock and one five-year warrant to purchase another share of common stock at $.15 per share.  The Company received net proceeds of $85,500, after deducting offering costs of $6,500.  The offering was made in reliance on exemptions from registration contained in Section 4(2) of the Securities Act of 1933, as amended, and Rule 506 of Regulation D promulgated thereunder.

In August 2006, the Company conducted a private placement offering whereby it sold 750,030 units at a price of $.15 per unit.  Each unit consisted of one share of the Company’s common stock and one five-year warrant to purchase another share of common stock at $.15 per share.  The warrants may be exercised over a period of five years. The Company received net proceeds of $101,749, after deducting offering costs of $10,700. The offering was made in reliance on exemptions from registration contained in Section 4(2) of the Securities Act of 1933, as amended, and Rule 506 of Regulation D promulgated thereunder.

In August 2006, the Company issued 43,336 shares of the Company’s common stock in exchange for commissions valued at $6,500. The shares were valued based on the fair value on the date of grant and are reflected in the accompanying financial statements as additional paid in capital.

In October 2006, the Company issued 13,687 shares of the Company’s common stock in exchange for $7,000 in interest on a convertible note payable November 11, 2006. The shares were valued based on the fair value of the shares in the period interest was accrued and are reflected in the accompanying financial statements as interest expense.

In December 2006, the Company issued 104,170 shares of the Company’s common stock in exchange for services valued at $25,000. The shares were valued based on the fair value on the date of grant and are reflected in the accompanying financial statements as professional and consulting fees.

In April 2007, the Company issued 16,669 shares of the Company’s common stock in exchange for services valued at $3,000. The shares were valued based on the fair value on the date of grant and are reflected in the accompanying financial statements as professional and consulting fees.

In May 2007, the Company issued 16,508 shares of the Company’s common stock in exchange for $4,225 in interest on a convertible note payable November 11, 2007.  The shares were valued based on the fair value of the shares in the period interest was accrued.
 
 
24

 
WORLDWIDE STRATEGIES INCORPORATED
(A Development Stage Company)
Notes to Financial Statements

On July 31, 2007, the Company issued 2,250,000 shares of the Company’s common stock to acquired 100% of the issued and outstanding shares of Centric.

Effective July 31, 2007, the Company filed a Certificate of Change Pursuant to NRS 78.209, which decreased the number of its authorized shares of common stock from 100,000,000 to 33,333,333 and reduced the number of common shares issued and outstanding from 17,768,607 to 5,923,106.

In August 2007, the Company issued 500,000 shares of the Company’s common stock to a noteholder at $.15, which was the fair value of the stock on the transaction date, in full payment for an outstanding $75,000 note payable on the completion of the Centric acquisition

In September 2007, the Company issued a total of 18,695 shares of the Company’s common stock in exchange for $3,937 in interest on three convertible notes payable November 2007, April 2008 and June 2008.  The shares were valued based on the fair value of the shares in the period interest was accrued.

In November 2007, the Company issued a total of 22,987 shares of the Company’s common stock in exchange for $2,813 in interest on two convertible notes payable May 2008 and April 2008.  The shares were valued based on the fair value of the shares in the period interest was accrued.

In January 2008, the Company issued 100,000 shares of the Company’s common stock at $.045 to an employee and a contractor as compensation for unpaid services.  The shares were valued based on their fair value when the share issuance was authorized.

In February 2008, the Company issued a total of 86,909 shares of the Company’s common stock in exchange for $4,275 in interest on four convertible notes payable May 2008, June 2008, September 2008 and October 2008.  The shares were valued based on the fair value of the shares in the period interest was accrued.

In May 2008, the Company issued a total of 31,514 shares of the Company’s common stock in exchange for $2,025 in interest on three convertible notes payable September 2008, October 2008 and December 2008.  The shares were valued based on the fair value of the shares in the period interest was accrued

In August 2008, the Company issued a total of 18,023 shares of the Company’s common stock in exchange for $2,469 in interest on five convertible notes payable May 2008, September 2008, October 2008 , December 2008 and January 2009.  The shares were valued based on the fair value of the shares in the period interest was accrued

In December 2008, the Company issued a total of 200,000 shares of the Company’s common stock in exchange for uncompensated services provided to the Company by one employee and four consultants. The shares were valued at $.03 per share based on the fair value of the shares in the month they were issued. This amount ($6,000) is reflected in the accompanying financial statements as stock based compensation

In April 2009, the Company issued 100,000 shares of the Company’s common stock in exchange for a $7,000 premium on a promissory note. This expense is reflected in the financial statements as interest expense.

In August 2009, the Company issued 25,000 shares of the Company’s common stock in exchange for services valued at $2,000. The shares were valued based on the fair value on the date of grant and are reflected in the accompanying financial statements as professional and consulting fees.

In September 2009, the Company issued 200,000 shares of the Company’s common stock in exchange for services valued at $10,000. The shares were valued based on the fair value on the date of grant and are reflected in the accompanying financial statements as professional and consulting fees.

In October 2009, the Company issued 20,000 shares of the Company’s common stock in exchange for services valued at $1,600. The shares were valued based on the fair value on the date of grant and are reflected in the accompanying financial statements as professional and consulting fees.
 
 
25

 
WORLDWIDE STRATEGIES INCORPORATED
(A Development Stage Company)
Notes to Financial Statements

In April 2010, the Company issued 25,000 shares of the Company’s common stock in exchange for services valued at $7,500. The shares were valued based on the fair value on the date of grant and are reflected in the accompanying financial statements as professional and consulting fees.

In September 2010, the Company issued 50,000 shares of the Company’s common stock in exchange for services valued at $3,000. The shares were valued based on the fair value on the date of grant and are reflected in the accompanying financial statements as professional and consulting fees.

In September 2010, the Company issued 387,500 common shares in payment for interest and renewal fees. The shares were valued at $.06 per share based on the fair value of the shares when they were issued. This amount ($23,250) is reflected in the accompanying financial statements as interest.

In January 2011, the Company issued 387,500 common shares in payment for interest and renewal fees. The shares were valued at $.24 per share based on the fair value of the shares when they were issued. This amount ($93,000) is reflected in the accompanying financial statements as interest.

In February 2011, the Company issued 50,000 shares of the Company’s common stock in exchange for services valued at $7,000. The shares were valued based on the fair value on the date of grant and are reflected in the accompanying financial statements as professional and consulting fees.

In April 2011, the Company issued 116,250 common shares in payment for interest and renewal fees. The shares were valued at $.08 per share based on the fair value of the shares when they were issued. This amount ($9,300) is reflected in the accompanying financial statements as interest

In May 2011, the Company issued 387,500 common shares in payment for interest and renewal fees. The shares were valued at $.14 per share based on the fair value of the shares when they were issued. This amount ($54,250) is reflected in the accompanying financial statements as $33,834 interest and $20,416 prepaid expenses, representing the amount to be amortized over the term of the renewal.

In July 2011, the Company issued 250,000 shares of the Company’s common stock in exchange for services valued at $37,500. The shares were valued based on the fair value on the date of grant and are reflected in the accompanying financial statements as professional and consulting fees.

In July 2011, the Company issued 116,250 common shares in payment for interest and renewal fees. The shares were valued at $.07 per share based on the fair value of the shares when they were issued. This amount ($8,138) is reflected in the accompanying financial statements as $8,138 interest and $7,350 prepaid expenses, representing the amount to be amortized over the term of the renewal.

In September 2011, the Company issued 387,500 shares of the Company’s common stock in exchange for interest and an extension of due date from September 18, 2011 to January 16, 2012 on a note payable. The shares, which were issued at $0.04 as per the note payable agreement, were valued at $0.15 per share based on the fair value of the shares when they were issued.  This amount ($58,125) is reflected in the accompanying financial statements as interest over the term of the note extension.

In November 2011, the Company issued 116,250 shares of the Company’s common stock in exchange for interest and an extension of due date from November 28, 2011 to March 27, 2012 on a note payable. The shares, which were issued at $0.04 as per the note payable agreement, were valued at $0.05 per share based on the fair value of the shares when they were issued.  This amount ($5,813) will be reflected in the accompanying financial statements as interest over the term of the note extension.

In December 2011, the Company issued 189,000 shares of the Company’s common stock in exchange for services to be rendered.

In December 2011, the Company issued 15,000 shares of the Company’s common stock in exchange for services to be rendered.
 
 
26

 
WORLDWIDE STRATEGIES INCORPORATED
(A Development Stage Company)
Notes to Financial Statements
 
In January 2012, the Company issued 387,500 shares of the Company’s common stock in exchange for interest and an extension of due date from January 16, 2012 to May 15, 2012 on a note payable. The shares, which were issued at $0.04 as per the note payable agreement, were valued at $0.5 per share based on the fair value of the shares when they were issued.  This amount ($19,373) is reflected in the accompanying financial statements as interest over the term of the note extension.

In January 2012, the Company issued 100,000 shares of the Company’s stock in exchange for services to be rendered.

In March 2012, the Company issued 116,250 shares of the Company’s common stock in exchange for interest and an extension of due date from March 27, 2012 to July 25, 2012 on a note payable. The shares, which were issued at $0.04 as per the note payable agreement, were valued at $0.05 per share based on the fair value of the shares when they were issued.  This amount ($5,813) is reflected in the accompanying financial statements as interest over the term of the note extension.

In March 2012, the Company issued 15,000 shares of the Company’s common stock in exchange for services to be rendered.  The shares were valued at $.05 per share based on the fair value of the shares when they were issued.  The amount ($750) is reflected in the accompanying financial statements as consulting fees.

In March 2012, the Company issued 15,000 shares of the Company’s common stock in exchange for services to be rendered.  The shares were valued at $.03 per share based on the fair value of the shares when they were issued.  The amount ($450) is reflected in the accompanying financial statements as consulting fees.

In May 2012, the Company issued 387,500 shares of the Company’s common stock in exchange for interest and an extension of due date from July 25, 2012 to September 12, 2012 on a note payable. The shares, which were issued at $0.04 as per the note payable agreement, were valued at $0.03 per share based on the fair value of the shares when they were issued.  This amount ($11,625) is reflected in the accompanying financial statements as interest over the term of the note extension.

In July 2012, the Company issued 300,000 shares of the Company’s common stock in exchange for services rendered.  The shares were valued at $.04 per share based on the fair value of the shares when they were issued.  The amount ($12,000) is reflected in the accompanying financial statements as consulting fees.

Options granted to employees, accounted for under the fair value method

Effective February 1, 2006, the Company adopted SFAS No. 123R, “Share Based Payment.”  SFAS 123R requires a public entity to measure the cost of employee services received in exchange for an award of equity instruments based on the grant-date fair value of the award (with limited exceptions).

On March 16, 2006, the Company granted options to an officer to purchase an aggregate of 100,000 shares of the Company’s common stock at an exercise price of $1.53 per share. 33,333 options were fully vested on the grant date, an additional 33,333 options vested on March 16, 2007, and the remaining 33,334 options vested on March 16, 2008.  All of the options expired on March 16, 2011.  In February 2007, the Company accelerated the vesting date to November 30, 2006; the date the officer left employment, and recognized $137,000 as stock based compensation in the accompanying financial statements to reflect the vested portion during the year ended July 31, 2007.  The total compensation costs for the modified share options were measured on the date of modification and no incremental costs resulted from the modification.  Therefore compensation costs reflected on the accompanying financial statements reflect the grant date fair value of the original award for which the requisite services have been rendered.  The fair value of the options was estimated at the date of grant using the Black-Scholes option-pricing model with the following assumptions:

Risk-free interest rate
4.60%
Dividend yield
0.00%
Volatility factor
140.00%
Weighted average expected life
5 years
 
 
27

 
WORLDWIDE STRATEGIES INCORPORATED
(A Development Stage Company)
Notes to Financial Statements

In June 2006, the Company granted ten of its officers, directors, and employees options to purchase an aggregate of 2,529,029 shares of the Company’s common stock at an exercise price of $.06 per share, in exchange for accrued compensation and expenses.  All 2,529,029 options were fully vested on the grant date.  The quoted market price of the stock was $.84 per share on the grant date.  The Company valued the options at $.84 per share, or $2,079,620.  This amount is reflected in the accompanying financial statements as stock based compensation.

In July 2006, the Company granted three of its officer options to purchase an aggregate of 199,000 shares of the Company’s common stock at an exercise price of $.15 per share, in exchange for accrued compensation and expenses.  All 199,000 options were fully vested on the grant date.  The quoted market price of the stock was $.75 per share on the grant date.  The Company valued the options at $.72 per share, or $143,101.  This amount is reflected in the accompanying financial statements as stock based compensation.  The fair value of the options was estimated at the date of grant using the Black-Scholes option-pricing model with the following assumptions:

Risk-free interest rate
4.97%
Dividend yield
0.00%
Volatility factor
Ranging from 139.92% to 140.00%
Weighted average expected life
5 years

In April 2007, the Company granted options to various officers, directors, and employees to purchase an aggregate of 933,338 shares of the Company’s common stock at an exercise price of $.18 per share.  All 933,338 were fully vested on the grant date.  The options had a fair value of $.18 per share or $164,360.  The fair value of the options was estimated at the date of grant using the Black-Scholes option-pricing model with the following assumptions:

Risk-free interest rate
4.97%
Dividend yield
0.00%
Volatility factor
202.07%
Weighted average expected life
5 years

In June 2007, the Company granted options to various officers, directors, and employees to purchase an aggregate of 933,338 shares of the Company’s common stock at an exercise price of $.24 per share.  All 933,338 were fully vested on the grant date.  The options had a fair value of $.24 per share or $221,200.  The fair value of the options was estimated at the date of grant using the Black-Scholes option-pricing model with the following assumptions:

Risk-free interest rate
4.97%
Dividend yield
0.00%
Volatility factor
220.80%
Weighted average expected life
5 years

On September 13, 2007, the Company extended the life of the options, originally granted June 22, 2007 to purchase 933,338 common shares of the Company, from a 5 year term to a 7 year term.  The options had a fair value of $.16 per share or $149,240.  No expense was recorded, as the revised fair value is less than the fair value originally recorded.  The fair value of the options was estimated at the date of grant using the Black-Scholes option-pricing model with the following assumptions:

Risk-free interest rate
4.97%
Dividend yield
0.00%
Volatility factor
268.16%
Weighted average expected life
7 years


 
28

 
WORLDWIDE STRATEGIES INCORPORATED
(A Development Stage Company)
Notes to Financial Statements


On September 13, 2007, the Company extended the life of the options, originally granted April 17, 2007 to purchase 933,338 common shares of the Company, from a 5 year term to a 7 year term.  The options had a fair value of $.16 per share or $149,240.  No expense was recorded, as the revised fair value is less than the fair value originally recorded.  The fair value of the options was estimated at the date of grant using the Black-Scholes option-pricing model with the following assumptions:

Risk-free interest rate
4.97%
Dividend yield
0.00%
Volatility factor
268.16%
Weighted average expected life
7 years

In May 2008, the Company granted options to various officers, directors, and employees to purchase an aggregate of 475,000 shares of the Company’s common stock at an exercise price of $.11 per share.  All 475,000 were fully vested on the grant date.  The options had a fair value of $.08 per share or $38,000.  The fair value of the options was estimated at the date of grant using the Black-Scholes option-pricing model with the following assumptions:

Risk-free interest rate
4.97%
Dividend yield
0.00%
Volatility factor
336.38%
Weighted average expected life
5 years

In December 2008, the Company granted two officers, five directors, one employee and four consultants options to purchase an aggregate of 600,000 shares of the Company’s common stock at an exercise price of $.015 per share, in exchange for unpaid services expenses.  All 600,000 options were fully vested on the grant date.  The quoted market price of the stock was $.02 per share on the grant date.  The Company valued the options at $.02 per share, or $12,000.  This amount is reflected in the accompanying financial statements as stock based compensation.  The fair value of the options was estimated at the date of grant using the Black-Scholes option-pricing model with the following assumptions:

Risk-free interest rate
4.97%
Dividend yield
0.00%
Volatility factor
139.92%
Weighted average expected life
5 years

In November 2011, the Company granted the VP Finance & CFO options to purchase an aggregate of 150,000 shares of the Company’s common stock at an exercise price of $.15 per share, in exchange for unpaid services expenses.  All 150,000 options were fully vested on the grant date.  The quoted market price of the stock was $.04 per share on the grant date.  The Company valued the options at $.04 per share, or $6,000.  This amount is reflected in the accompanying financial statements as stock based compensation.  The fair value of the options was estimated at the date of grant using the Black-Scholes option-pricing model with the following assumptions:

Risk-free interest rate
2.01%
Dividend yield
0.00%
Volatility factor
619.63%
Weighted average expected life
5 years

In March 2012, the Company granted the VP Finance & CFO options to purchase an aggregate of 150,000 shares of the Company’s common stock at an exercise price of $.15 per share, in exchange for unpaid services expenses.  All 150,000 options were fully vested on the grant date.  The quoted market price of the stock was $.04 per share on the grant date.  The Company valued the options at $.04 per share, or $6,000.  This amount is reflected in the accompanying financial statements as stock based compensation.  The fair value of the options was estimated at the date of grant using the Black-Scholes option-pricing model with the following assumptions:

 
29

 
WORLDWIDE STRATEGIES INCORPORATED
(A Development Stage Company)
Notes to Financial Statements


Risk-free interest rate
2.31%
Dividend yield
0.00%
Volatility factor
619.63%
Weighted average expected life
5 years

Options granted to employees, accounted for under the intrinsic value method

On April 30, 2005, the Company granted four directors options to purchase an aggregate of 120,000 shares of the Company’s common stock at an exercise price of $.75 per share.  40,000 options were fully vested on the grant date, an additional 40,000 options vested on April 30, 2006, and the remaining 40,000 options vested on April 30, 2007.  All of the options expired on April 30, 2010.  The exercise price of the options equaled the price at which the Company was selling the stock to unrelated third parties on the grant date.  The Company’s common stock had no quoted market price on the grant date.  No stock-based compensation was recorded on the options through January 31, 2006.  The options had a fair value of $.093 per share, or $11,160.  Effective February 1, 2006, the Company adopted SFAS No. 123R, “Share Based Payment” and recognized $2,093 and $1,395 as stock based compensation in the accompanying financial statements to reflect the vested portion during the period from the effective date through July 31, 2007 and July 31, 2006.

On August 18, 2005, the Company granted three officers options to purchase an aggregate of 233,334 shares of the Company’s common stock at an exercise price of $.75 per share.  100,000 options were fully vested on the grant date, an additional 100,000 options vested on April 30, 2006, and the remaining 33,334 options vested on April 30, 2007.  All of the options expired on April 30, 2010.  The exercise price of the options equaled the price at which the Company was selling the stock to unrelated third parties on the grant date.  The Company’s common stock had no quoted market price on the grant date.  No stock-based compensation was recorded on the options through January 31, 2006.  The options had a fair value of $.093 per share, or $21,700.  Effective February 1, 2006, the Company adopted SFAS No. 123R, “Share Based Payment” and recognized $1,329 and $4,650 as stock based compensation in the accompanying financial statements to reflect the vested portion during the period from the effective date through July 31, 2007 and July 31, 2006.

On September 30, 2005, the Company granted a director options to purchase an aggregate of 30,000 shares of the Company’s common stock at an exercise price of $3.36 per share.  10,000 options were fully vested on the grant date, an additional 10,000 options vested on September 30, 2006, and the remaining 10,000 options vested on September 30, 2007.  All of the options expired on September 30, 2010.  The exercise price of the options equaled the traded market price of the stock on the grant date.  No stock-based compensation was recorded on the options through January 31, 2006.  The options had a fair value of $.42 per share, or $12,600.  Effective February 1, 2006, the Company adopted SFAS No. 123R, “Share Based Payment” and recognized $2,928 and $2,100 as stock based compensation in the accompanying financial statements to reflect the vested portion during the period from the effective date through July 31, 2007 and July 31, 2006.

The fair value of the options was estimated at the date of grant using the Black-Scholes option-pricing model with the following assumptions:
Risk-free interest rate
2.70%
Dividend yield
0.00%
Volatility factor
0.00%
Weighted average expected life
5 years

Had compensation expense been recorded based on the fair value at the grant date, and charged to expense over vesting periods, for periods prior to February 1, 2006, the Company’s net loss and net loss per share would have increased to the pro forma amounts indicated below:

 
30

 
WORLDWIDE STRATEGIES INCORPORATED
(A Development Stage Company)
Notes to Financial Statements



             
March 1, 2005
 
 
Year
   
Year
   
(Inception)
 
 
Ended
   
Ended
   
Through
 
 
July 31, 2012
   
July 31, 2011
   
July 31, 2012
 
Net loss, as reported
$
(317,042
)
 
$
(500,394
)
 
$
(7,676,380
)
   Decrease due to:
                     
       Employee stock options
 
-
     
-
     
(29,453
)
Pro forma net loss
$
(317,042
)
 
$
(500,394
)
 
$
(7,705,833
)
                       
As reported:
                     
    Net loss per share - basic and diluted
$
(0.013
)
 
$
(0.022
)
       
Pro Forma:
                     
    Net loss per share - basic and diluted
$
(0.013
)
 
$
(0.022
)
       

The following schedule reflects the calculation of the pro forma compensation expense on employee stock options:

Date of Grant
 
Number of Options Granted
   
Total Fair Value
   
Options Vested Through
July 31, 2008
   
Fair Value Incurred Through
July 31, 2008
 
4/30/2005
   
100,000
   
$
11,160
     
100,000
   
$
6,510
 
8/18/2005
   
233,334
     
21,700
     
233,334
     
15,721
 
9/30/2005
   
30,000
     
12,600
     
30,000
     
7,222
 
     
363,334
   
$
45,460
     
363,334
   
$
29,453
 

$4,650 of the stock options’ total fair value incurred through July 31, 2008 ($29,453) was recognized during the period from March 1, 2005 (Inception) through July 31, 2005.

Options granted to non-employees, accounted for under the fair value method

In June 2006, the Company granted two consultants options to purchase an aggregate of 325,000 shares of the Company’s common stock at an exercise price of $.06 per share, in exchange for accrued expenses.  All 325,000 options were fully vested on the grant date.  The quoted market price of the stock was $.84 per share on the grant date.  The Company valued the options at $.82 per share, or $267,248.  This amount is reflected in the accompanying financial statements as stock based compensation.  The fair value of the options was estimated at the date of grant using the Black-Scholes option-pricing model with the following assumptions:

Risk-free interest rate
4.97%
Dividend yield
0.00%
Volatility factor
139.92%
Weighted average expected life
5 years

In April 2007, the Company granted options to a consultant to purchase an aggregate of 133,334 shares of the Company’s common stock at an exercise price of $.18 per share.  All 133,334 were fully vested on the grant date.  The options had a fair value of $0.06 per share or $23,480.  The fair value of the options was estimated at the date of grant using the Black-Scholes option-pricing model with the following assumptions:

Risk-free interest rate
4.97%
Dividend yield
0.00%
Volatility factor
202.07%
Weighted average expected life
5 years
 
 
 
31

 
WORLDWIDE STRATEGIES INCORPORATED
(A Development Stage Company)
Notes to Financial Statements
 
In June 2007, the Company granted options to a consultant to purchase an aggregate of 133,334 shares of the Company’s common stock at an exercise price of $.24 per share.  All 133,334 were fully vested on the grant date.  The options had a fair value of $.24 per share or $31,600.  The fair value of the options was estimated at the date of grant using the Black-Scholes option-pricing model with the following assumptions:

Risk-free interest rate
4.97%
Dividend yield
0.00%
Volatility factor
220.80%
Weighted average expected life
5 years

On September 13, 2007 the Company extended the life of the options, originally granted June 22, 2007 to purchase 133,334 common shares of the Company, from a 5 year term to a 7 year term. The options had a fair value of $.24 per share or $21,320. No expense was recorded as the revised fair value is less than the fair value originally recorded.  The fair value of the options was estimated at the date of grant using the Black-Scholes option-pricing model with the following assumptions:
Risk-free interest rate
4.97%
Dividend yield
0.00%
Volatility factor
268.16%
Weighted average expected life
7 years

On September 13, 2007 the Company extended the life of the options, originally granted April 17, 2007 to purchase 133,334 common shares of the Company, from a 5 year term to a 7 year term. The options had a fair value of $.24 per share or $21,320. No expense was recorded, as the revised fair value is less than the fair value originally recorded.  The fair value of the options was estimated at the date of grant using the Black-Scholes option-pricing model with the following assumptions:

Risk-free interest rate
4.97%
Dividend yield
0.00%
Volatility factor
268.16%
Weighted average expected life
7 years

Following is a schedule of changes in common stock options and warrants from March 1, 2005 (inception) through July 31, 2012:



                     
Weighted
   
Weighted
 
                     
Average
   
Average
 
               
Exercise
   
Exercise
   
Remaining
 
   
Awards Outstanding
   
Price
   
Price
   
Contractual
 
   
Total
   
Exercisable
   
Per Share
   
Per Share
   
Life
 
Outstanding at March 31, 2005 (Inception)
    -       -     $ -     $ -       -  
Granted
    3,026,667       3,026,667     $ 0.75     $ 0.75    
.79 years
 
Exercised
    -       -     $ -     $ -       N/A  
Cancelled/Expired
    (20,000 )     (20,000 )   $ -     $ -       N/A  
Outstanding at July 31, 2005
    3,006,667       3,006,667     $ 0.75     $ 0.75    
.79 years
 
                                         
Granted
    4,793,029       4,793,029     $ 0.06-$3.36     $ 0.35    
1.69 years
 
Exercised
    -       -     $ -     $ -       N/A  
Cancelled/Expired
    -       -     $ -     $ -       N/A  
Outstanding at July 31, 2006
    7,799,696       7,799,696     $ 0.06-$3.36     $ 0.50    
1.34 years
 
 
 
 
32

 
WORLDWIDE STRATEGIES INCORPORATED
(A Development Stage Company)
Notes to Financial Statements
 
                                         
Granted
    2,883,363       2,883,363     $ 0.18-$0.75     $ 0.35    
4.09 years
 
Exercised
    -       -     $ -     $ -       N/A  
Cancelled/Expired
    -       -     $ -     $ -       N/A  
Outstanding at July 31, 2007
    10,683,059       10,683,059     $ 0.06-$3.36     $ 0.46    
2.08 years
 
                                         
Granted
    475,000       475,000     $ 0.11     $ 0.11    
3.83 years
 
Exercised
    -       -     $ -     $ -       N/A  
Cancelled/Expired
    -       -     $ -     $ -       N/A  
Outstanding at July 31, 2008
    11,158,059       11,158,059     $ 0.06-$3.36     $ 0.45    
2.16 years
 
                                         
Granted
    600,000       600,000     $ 0.02     $ 0.02       4.36  
Exercised
    -       -     $ -     $ -       N/A  
Cancelled/Expired
    -       -     $ -     $ -       N/A  
Outstanding at July 31, 2009
    11,758,059       11,758,059     $ 0.015-$3.36     $ 0.42    
2.27 years
 
                                         
Granted
    -       -     $ -     $ -       N/A  
Exercised
    -       -     $ -     $ -       N/A  
Cancelled/Expired
    (3,323,370 )     (3,323,370 )   $ 0.75     $ 0.75       N/A  
Outstanding at July 31, 2010
    8,434,689       8,434,689     $ 0.015-$3.36     $ 0.42    
1.86 years
 
                                         
Granted
    -       -     $ -     $ -       N/A  
Exercised
    -       -     $ -     $ -       N/A  
Cancelled/Expired
    (4,476,360 )     (4,476,360 )   $ 0.06-$3.36     $ -       N/A  
Outstanding at July 31, 2011
    3,958,329       3,958,329     $ 0.015-$0.75     $ 0.23    
1.09 years
 
                                         
Granted
    300,000       300,000     $ 0.15     $ 0.15       N/A  
Exercised
    -       -     $ -     $ -       N/A  
Cancelled/Expired
    (750,001 )     (750,001 )   $ 0.75     $ -       N/A  
Outstanding at July 31, 2012
    3,508,328       3,508,328     $ 0.015-$0.24     $ 0.16    
1.82 years
 

Common stock awards consisted of the following options and warrants during the period from March 1, 2005 (inception) through July 31, 2012:

             
Total
   
Description
 
Options
   
Warrants
 
Awards
   
Outstanding at March 31, 2005 (inception)
   
-
     
-
   
-  
   
Granted
   
120,000
     
2,906,667
   
3,026,667 
   
Exercised
   
-
     
-
   
   
Cancelled/Expired
   
(20,000
   
-
   
(20,000)
   
Outstanding at July 31, 2005
   
100,000
     
2,906,667
   
3,006,667 
   
                         
Granted
   
3,416,362
     
1,376,667
   
4,793,029 
   
Exercised
   
-
     
-
   
   
Cancelled/Expired
   
-
     
-
   
   
Outstanding at July 31, 2006
   
3,516,362
     
4,283,334
   
7,799,696 
   
 
 
 
33

 
WORLDWIDE STRATEGIES INCORPORATED
(A Development Stage Company)
Notes to Financial Statements
 
                         
Granted
   
2,133,333
     
750,030
   
2,883,363 
   
Exercised
   
-
     
-
   
   
Cancelled/Expired
   
-
     
-
   
   
Outstanding at July 31, 2007
   
5,649,695
     
5,033,364
   
10,683,059 
   
                         
Granted
   
475,000
     
-
   
475,000 
   
Exercised
   
-
     
-
   
   
Cancelled/Expired
   
-
     
-
   
   
Outstanding at July 31, 2008
   
6,124,695
     
5,033,364
   
11,158,059 
   
                         
Granted
   
600,000
     
-
   
600,000 
   
Exercised
   
-
     
-
   
   
Cancelled/Expired
   
 -
     
-
   
   
Outstanding at July 31, 2009
   
6,724,695
     
5,033,364
   
11,758,059 
   
                         
Granted
   
 -
     
 -
   
              -
   
Exercised
   
 -
     
 -
   
              -
   
Cancelled/Expired
   
(333,339
   
(2,990,031
 
(3,323,370)
   
Outstanding at July 31, 2010
   
6,391,356
     
2,043,333
   
8,434,689 
   
                         
Granted
   
 -
     
 -
   
              -
   
Exercised
   
 -
     
 -
   
              -
   
Cancelled/Expired
   
(3,183,028
   
(1,293,332
 
(4,476,360)
   
Outstanding at July 31, 2011
   
3,208,328
     
750,001
   
3,958,329 
   
                         
Granted
   
300,000
     
 -
   
     300,000 
   
Exercised
   
 -
     
 -
   
              -
   
Cancelled/Expired
   
-
     
(750,001
 
(750,001)
   
Outstanding at July 31, 2012
   
3,508,328
     
-0-
   
3,508,328 
   
 
(7)           Income Taxes

A reconciliation of U.S. statutory federal income tax rate to the effective rate follows:

 
For The Years Ended
 
July 31,
 
2012
 
2011
U.S. statutory federal rate, graduated
34.00%
 
34.00%
State income tax rate, net of federal
3.06%
 
3.06%
Net operating loss (NOL) for which
     
    no tax benefit is currently available
-37.06%
 
-37.06%
 
0.00%
 
0.00%

At July 31, 2012, the Company fully allowed for any deferred tax asset that it may have as a result of its accumulated losses of $7,676,380.  The valuation allowance offsets the net deferred tax asset for which it is more likely than not that the deferred tax assets will not be realized.   The net operating loss carry-forward expires through the year 2031.
 
 
34

 
WORLDWIDE STRATEGIES INCORPORATED
(A Development Stage Company)
Notes to Financial Statements

The valuation allowance will be evaluated at the end of each year, considering positive and negative evidence about whether the deferred tax asset will be realized.  At that time, the allowance will either be increased or reduced; reduction could result in the complete elimination of the allowance if positive evidence indicates that the value of the deferred tax assets is no longer impaired and the allowance is no longer required.

Should the Company undergo an ownership change as defined in Section 382 of the Internal Revenue Code, the Company’s tax net operating loss carry-forwards generated prior to the ownership change will be subject to an annual limitation, which could reduce or defer the utilization of these losses.

(8)           Commitments

Beginning February 2007, the Company commenced a month-to-month lease on a “virtual” office at a rate of $150 per month.  Rent expense for the years ended July 31, 2012 and 2011 and for the period from March 1, 2005 (inception) through July 31, 2012 totaled $1,800, $1,800 and $54,831, respectively.

(9)           Concentration of Credit Risk for Cash

The Company has concentrated its credit risk for cash by maintaining deposits in a financial institution, which may at times exceed the amounts covered by insurance provided by the United States Federal Deposit Insurance Corporation (“FDIC”).  At July 31, 2012, the loss that would have resulted from that risk totaled $-0-.  The Company has not experienced any losses in such accounts and believes it is not exposed to any significant credit risk to cash.

(10)           Subsequent Events

In August 2012, the Company issued a convertible promissory note to an unrelated party in exchange for $15,000.

In August 2012, the Company issued 150,000 shares of the Company’s common stock to its VP Finance & CFO as compensation for services to be rendered for the fiscal year ended July 31, 2012.

In August 2012, the Company issued options to purchase 550,000 shares of common stock to its VP Finance & CFO and four directors as compensation for services rendered.

In August 2012, the Company issued 116,250 shares of the Company’s common stock in exchange for interest and an extension on the due date of a Promissory Note.

In September 2012, the Company issued 387,500 shares of the Company’s common stock in exchange for interest and an extension on the due date of a Promissory Note.

In October 2012, the Company issue convertible promissory notes to unrelated parties in exchange for $7,500.

In October 2012, the Company issued 350,000 shares of the Company’s common stock in exchange for services rendered.

In October 2012, the Company reached agreement in principle to settle the accrued salaries and expenses owed James P.R. Samuels and W. Earl Somerville.  As of September 7, 2012 these amounts totaled $346,926 and 168,801 respectively.  The agreement includes Mr. Samuels and Mr. Somerville forgiving a significant amount and receiving convertible promissory notes.  Ownership of the company’s United Kingdom subsidiary, Worldwide Business Solutions Limited, would also be transferred to Mr. Samuels in this agreement.



 
35

 


ITEM 9.CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

There were no changes in or disagreements with accountants during the last two completed fiscal years and the interim period ending as of the date of this report.

ITEM 9A.CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

As required by SEC rules, we have evaluated the effectiveness of the design and operation of our disclosure controls and procedures at the end of the period covered by this report.  This evaluation was carried out under the supervision and with the participation of our management, including our principal executive officer and principal financial officer.  Based on this evaluation, these officers have concluded that the design and operation of our disclosure controls and procedures are effective.

Disclosure controls and procedures are our controls and other procedures that are designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms.  Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by us in the reports that we file under the Exchange Act is accumulated and communicated to our management, including principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure.

Changes in Internal Controls over Financial Reporting

Our principal executive officer and principal financial officer have concluded that there were no changes in our internal control over financial reporting that occurred during the fiscal quarter ended July 31, 2012 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Management’s Annual Report on Internal Control over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting.  Internal control over financial reporting is a process designed by, or under the supervision of, our chief financial officer and implemented by our board of directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles.

Our evaluation of internal control over financial reporting includes an analysis under the COSO framework, an integrated framework for the evaluation of internal controls issued to identify the risks and control objectives related to the evaluation of the control environment by the Committee of Sponsoring Organizations of the Treadway Commission.

Based on our evaluation described above, our management has concluded that our internal control over financial reporting was effective during the fiscal year ended July 31, 2012.

Respectfully,

James P.R. Samuels, Chief Executive Officer
Thomas E. McCabe, Chief Financial Officer


 
36

 

 
ITEM 9B.OTHER INFORMATION

None.

PART III

ITEM 10.
DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

Executive Officers and Directors

Our executive officers and directors are:

Name
Age
Position
James P.R. Samuels
65
President, Chief Executive Officer and Director
Thomas E. McCabe
54
VP Finance, Chief Financial Officer, Secretary
Frank J. Deleo
56
Director
Robert T. Kane
67
Director
Edward J. Weisberg
55
Director
Gregory Kinney
50
Director

Our articles of incorporation and bylaws provide for the maximum indemnification of our officer and director allowable under Nevada corporate law.  Our shareholders elect our directors annually and our board of directors appoints our officers annually.  Vacancies in our board are filled by the board itself.  Set forth below are brief descriptions of the recent employment and business experience of our executive officers and directors.

James P.R. Samuels, Chief Executive Officer and Director.  Mr. Samuels founded Worldwide Business Solutions Incorporated in March 2005 and has been the chief executive officer and a director of the company since June 2005.  From May 1996 to March 2004, he served as vice president-finance, treasurer and chief financial officer of Rentech, Inc., a publicly-held company headquartered in Denver, Colorado.  Rentech develops and markets processes for conversion of low-value carbon-bearing solids or gases into high-value hydrocarbons.  From December 1995 through April 1998, he provided consulting services in finance and securities law compliance to Telepad Corporation, Herndon, Virginia, a company engaged in systems solutions for field force computing.  From 1991 through August 1995, he served as chief financial officer, vice president-finance, treasurer and director of Top Sources, Inc., Palm Beach Gardens, Florida, a development stage company engaged in developing and commercializing technologies for the transportation, industrial and petrochemical markets.  From 1989 to 1991, he was vice president and general manager of the automotive group of BML Corporation, Mississauga, Ontario, a privately-held company engaged in auto rentals, car leasing, and automotive insurance.  From 1989 to 1991, he was vice president and general manager of the automotive group of BML Corporation, Mississauga, Ontario, a privately-held company engaged in auto rentals, car leasing, and automotive insurance.  From 1983 through 1989, Mr. Samuels was employed by Purolator Products Corporation, a large manufacturer and distributor of automotive parts.  He was president of the Mississauga, Ontario branch from 1985 to 1989; a director of marketing from 1984 to 1985; and director of business development and planning during 1983 for the Rahway, New Jersey filter division headquarters of Purolator Products Corporation.  From 1975 to 1983, he was employed by Bendix Automotive Group, Southfield, Michigan, a manufacturer of automotive filters, electronics and brakes.  He served in various capacities, including group director for management consulting services on the corporate staff, director of market research and planning, manager of financial analysis and planning, and plant controller at its Fram Autolite division.  From 1973 to 1974, he was employed by Bowmar Ali, Inc., of Acton, Massachusetts, in various marketing and financial positions, and in 1974 he was managing director of its division in Wiesbaden, Germany.  He received a Bachelor’s degree in Business Administration from Lowell Technological Institute in 1970, and a Master of Business Administration degree in 1972 from Suffolk University, Boston, Massachusetts.  He completed an executive program in strategic market management through Harvard University in Switzerland in 1984.

We believe that Mr. Samuels should serve on the board because of his previous experience in management and with publicly held companies.

 
37

 
Thomas E. McCabe, VP Finance and Chief Financial Officer. Thomas McCabe has been our chief financial officer since October 2011.  He has over 25 years experience in public and privately held companies.  Mr. McCabe’s corporate leadership roles include President, CFO, General Manager, Senior Vice President, Vice President of Administration, Vice President Information Technology, Manufacturing Manager and Controller. His educational background includes a BS in Math/Business from Wake Forest University and an MBA from the University of Florida.  Mr. McCabe started TEM Associates in 2009 with a primary focus on providing C-level guidance, support and services to start-up, early-stage and small/medium sized companies, focusing primarily on CFO related activities.  TEM Associates also provides investment evaluation services to Private Equity investors, support for acquisition execution and assorted project and interim C-level support.

Frank J. Deleo, Director.  Mr. Deleo has been a director since June 2005.  Since September 2007, Mr. Deleo has served as president of Rioath Group.  Mr. Deleo was with Citigroup Inc. from 1978 to September 2007.  He was with CitiFinancial Branch Network from 1996, first as a vice president/regional manager and since March 2002 as a managing director over Texas, New Mexico, Oklahoma, and Kansas.  CitiFinancial, which is part of Citigroup Inc., a financial services company listed on the New York Stock Exchange, offers consumer loan products and services, including real estate, personal loans, and loans to finance consumer goods.  From 1979 to 1996, he was employed by Associates Corporation of North America.  Mr. Deleo received a bachelors degree in psychology from University of Stony Brook University in 1977.

We believe that Mr. Deleo should serve on the board because of his previous experience in financial services and management with publicly held companies.

Robert T. Kane, Director. Robert Kane has been a director since June 2005.  He has been a practicing attorney in Munhall, Pennsylvania, since 1970.  Mr. Kane received his J.D. degree from Villanova University in 1970 and his B.S. degree from Pennsylvania State University in 1965.

We believe Mr. Kane should serve on the board because of his experience in corporate oversight, litigation and general corporate law practice.

Edward J. Weisberg, Director.  Mr. Weisberg has been a director since September 2005.  He is currently Vice President of Marketing and Business Development at GXT Green, a division of Global Exchange Technologies.  GXT Green develops and sells carbon offsets globally, as well as offers a set of sustainability services and products, including ECOgrade photodegradable shopping bags.  Mr. Weisberg has also been the Managing Partner of Ecommerce Expertise, a consulting practice dedicated to assisting companies with Internet marketing and improving eCommerce profitability, since September 2008.  From December 2009 to August 2010, he held the position of Director of Business Development at Keyword Connects, LLC, an online lead generation company based in Waltham, Massachusetts.  From January 2008 to October 2009, he was Vice President of Innovaro (formerly UTEK) Corporation, a public corporation based in Tampa, Florida, which provides innovation and patent licensing services.  From April 2004 to July 2007, he was the vice president of eCommerce of iBasis, Inc., a publicly-held company based in Burlington, Massachusetts, that provides international Voice over Internet Protocol (VoIP) services.  He was responsible for leading that company’s efforts toward direct web-based sales of products and services.  From 1995 until April 2003, he co-founded and served as president of PureCommerce, Inc. (formerlyBX.COM Inc.), a Providence, Rhode Island company that provides eCommerce web site development, hosting, and Internet marketing support.  Prior to founding BX.com, he held various key marketing, planning, and sales roles at Paradigm Management Consulting Group, Inc., BASF Corporation, Data General Corporation, and Wang Laboratories, Inc.  Mr. Weisberg is also on the board of advisors of Sustainable Minds, LLC, and ZebraTickets, LLC, both privately-held companies.  Mr. Weisberg has a Masters degree in management from MIT/Sloan School of Management and a bachelors degree in social psychology from the University of Pennsylvania.

We believe Mr. Weisberg should serve on the board because of his previous experience in management, marketing, emerging technology and with publicly held companies.

Gregory Kinney, Director.  Formerly a director of Centric, Mr. Kinney was appointed to serve as a director on August 1, 2007.  Since April 1997 to the present, Mr. Kinney has served as Vice-President of Operations of Kristel, LP, a privately held organization operating in Illinois.  Kristel designs and manufactures LCD and CRT
 
 
38

 
displays.  From 1984 to 1997, Mr. Kinney worked in a variety of positions with The Bradley Group, American Instruments, Strand Lighting Company, Northrop, and Amistar.  Between 1980 and 1984, Mr. Kinney served in the United States Navy.  Mr. Kinney has received a B.A., M.A., and Ph.D. in Clinical Christian Counseling from International Theological Seminary in Bradenton Florida.
 
We believe Mr. Weisberg should serve on the board because of his previous experience in management and with the technology sector.

Committees

Audit Committee.  Our audit committee members are Edward J. Weisberg and Robert T. Kane.  The Audit Committee is appointed by the Board of Directors to assist the Board in fulfilling its responsibility to oversee (1) the integrity of our financial statements, controls and disclosure; (2) the qualifications and independence of our independent accountants; (3) the performance of our independent accountants and of its internal audit staff; and (4) our compliance with legal and regulatory requirements.

The Audit Committee has the sole authority to appoint our independent accountants, subject to any shareholder ratification.  The Audit Committee also prepares the annual Audit Committee report required by the rules and regulations of the Securities and Exchange Commission to be included in our annual proxy statement.

We believe that until such time as the Company acquires a business that it is not necessary to have a financial expert serving on the audit committee.

Compensation Committee.  Our compensation committee members are Frank J. Deleo and Gregory Kinney.  The Compensation Committee is appointed by the Board of Directors to (1) discharge the responsibilities of the Board of Directors relating to compensation of our executives and (2) produce an annual report on executive compensation for inclusion in our proxy statement in accordance with applicable rules and regulations.

Nominating Committee.  During the fiscal year ended July 31, 2012, the Company established a Nominating Committee for board membership.  Committee members are Gregory Kinney and Frank J. Deleo.  The Nominating Committee is appointed by the Board of Directors to identify, review credentials of and recommend membership of new board members.

Family Relationships

There is no family relationship between any director, executive or person nominated or chosen by us to become a director or executive officer of our company.

Conflicts of Interest

Members of our management are associated with other firms involved in a range of business activities.  Consequently, there are potential inherent conflicts of interest in their acting as officers and directors of our company.  While the officers and directors are engaged in other business activities, we anticipate that such activities will not interfere in any significant fashion with the affairs of our business, in terms of having adequate time to devote to the business of the company.

Our officers and directors are now and may in the future become shareholders, officers or directors of other companies, which may be formed for the purpose of engaging in business activities similar to us.  Accordingly, additional direct conflicts of interest may arise in the future with respect to such individuals acting on behalf of us or other entities.  Moreover, additional conflicts of interest may arise with respect to opportunities which come to the attention of such individuals in the performance of their duties or otherwise.  Currently, we do not have a right of first refusal pertaining to opportunities that come to their attention and may relate to our business operations.

Our officers and directors are, so long as they are our officers or directors, subject to the restriction that all opportunities contemplated by our plan of operation which come to their attention, either in the performance of their duties or in any other manner, will be considered opportunities of, and be made available to us and the companies
 
 
39

 
 
that they are affiliated with on an equal basis.  A breach of this requirement will be a breach of the fiduciary duties of the officer or director.  If we or the companies with which the officers and directors are affiliated both desire to take advantage of an opportunity, then said officers and directors would abstain from negotiating and voting upon the opportunity.  However, all directors may still individually take advantage of opportunities if we should decline to do so.  Except as set forth above, we have not adopted any other conflict of interest policy with respect to such transactions.

Code of Ethics

We have not yet adopted a code of ethics that applies to our principal executive officers, principal financial officer, principal accounting officer or controller, or persons performing similar functions, since we have been focusing our efforts on obtaining financing for the company.  We expect to adopt a code by the end of the current fiscal year.

Procedure for Nominating Directors

During the fiscal year ended July 31, 2012, the Board of Directors established a Nominating Committee through which security holders may recommend nominees to our board of directors.

The board of directors will consider candidates for director positions that are recommended by any of our stockholders and approved by the Nominating Committee.  Any such recommendation for the annual meeting of stockholders should be provided to our corporate secretary by December 31, 2012.  The recommended candidate should be submitted to us in writing addressed to 3801 East Florida Avenue, Suite 400, Denver, Colorado  80210.  The recommendation must include the following information: name of candidate; address, phone, and fax number of candidate; a statement signed by the candidate certifying that the candidate wishes to be considered for nomination to our board of directors and stating why the candidate believes that he or she would be a valuable addition to our board of directors; a summary of the candidate’s work experience for the prior five years and the number of shares of our stock beneficially owned by the candidate.

The Nominating Committee will evaluate any recommended candidate and determine whether or not to proceed with the candidate in accordance with our procedures.  We reserve the right to change our procedures at any time to comply with the requirements of applicable laws.

Section 16(a) Beneficial Ownership Reporting Compliance

Officers and directors, and persons who own more than 10% of a registered class of the Company’s equity securities, are required to file reports of ownership and changes in ownership with the Securities and Exchange Commission pursuant to Section 16(a) of the Securities Exchange Act of 1934.  The following table sets forth reports that were not filed on a timely basis during the most recently completed fiscal year:

Reporting Person
Date Report Due
Date Report Filed
Christensen , Donald A.
Form 4 due December 16, 2008
Not yet filed
Christensen , Donald A.
Form 4 due December 30, 2008
Not yet filed
Christensen , Donald A.
Form 4 due February 5, 2009
Not yet filed
Christensen, Donald A.
Form 4 due May 21, 2010
Not yet filed
Deleo, Frank J.
Form 4 due December 16, 2008
Not yet filed
Deleo, Frank J.
Form 4 due December 30, 2008
Not yet filed
Deleo, Frank J.
Form 4 due May 21, 2010
Not yet filed
Deleo, Frank J.
Form 4 due August 12, 2011
Not yet filed
Deleo, Frank J.
Form 4 due April 3, 2012
Not yet filed
Kane, Robert T.
Form 4 due December 16, 2008
Not yet filed
Kane, Robert T.
Form 4 due December 30, 2008
Not yet filed
Kane, Robert T.
Form 4 due February 5, 2009
Not yet filed
Kane, Robert T.
Form 4 due May 21, 2010
Not yet filed
Kane, Robert T.
Form 4 due August 12, 2011
Not yet filed
 
 
 
40

 
 
 
Reporting Person Date Report due Date Report Filed
Kane, Robert T.
Form 4 due November 3, 2011
Not yet filed
Kinney, Gregory
Form 4 due December 16, 2008
Not yet filed
Kinney, Gregory
Form 4 due December 30, 2008
Not yet filed
Kinney, Gregory
Form 4 due May 21, 2010
Not yet filed
Kinney, Gregory
Form 4 due August 12, 2011
Not yet filed
Kinney, Gregory
Form 4 due November 3, 2011
Not yet filed
McCabe, Thomas E.
Form 3 due November 11, 2011
Not yet filed
McCabe, Thomas E.
Form 4 due March 20, 2012
Not yet filed
Samuels, James P.R.
Form 4 due December 16, 2008
Not yet filed
Samuels, James P.R.
Form 4 due December 30, 2008
Not yet filed
Samuels, James P.R.
Form 4 due February 5, 2009
Not yet filed
Samuels, James P.R.
Form 4 due May 4, 2009
Not yet filed
Samuels, James P.R.
Form 4 due July 6, 2009
Not yet filed
Samuels, James P.R.
Form 4 due May 21, 2010
Not yet filed
Somerville, W. Earl
Form 4 due December 16, 2008
Not yet filed
Somerville, W. Earl
Form 4 due December 30, 2008
Not yet filed
Somerville, W. Earl
Form 4 due February 5, 2009
Not yet filed
Somerville, W. Earl
Form 4 due May 4, 2009
Not yet filed
Somerville, W. Earl
Form 4 due May 21, 2010
Not yet filed
Rudolf and Monique van den Brink
Form 3 due December 13, 2010
Not yet filed
Rudolf and Monique van den Brink
Form 4 due January 27, 2011
Not yet filed
Rudolf and Monique van den Brink
Form 4 due July 13, 2011
Not yet filed
Rudolf and Monique van den Brink
Form 4 due October 10, 2011
Not yet filed
Rudolf and Monique van den Brink
Form 4 due December 6, 2011
Not yet filed
Rudolf and Monique van den Brink
Form 4 due January 23, 2012
Not yet filed
Rudolf and Monique van den Brink
Form 4 due March 20, 2012
Not yet filed
Rudolf and Monique van den Brink
Form 4 due May 22, 2012
Not yet filed
Weisberg, Edward J.
Form 4 due December 16, 2008
Not yet filed
Weisberg, Edward J.
Form 4 due December 30, 2008
Not yet filed
Weisberg, Edward J.
Form 4 due February 5, 2009
Not yet filed
Weisberg, Edward J.
Form 4 due May 21, 2010
Not yet filed
Weisberg, Edward J.
Form 4 due August 12, 2011
Not yet filed

ITEM 11.EXECUTIVE COMPENSATION

The following table sets forth information regarding the remuneration of our chief executive officer and any executive officers that earned in excess of $100,000 per annum during any part of the last two completed fiscal years ending July 31, 2012.

Summary Compensation Table
Name and principal position
Year
Salary ($)
Bonus ($)
Stock Awards
($)
Option Awards
($)
All Other
Compensation ($)
Total ($)
James P.R. Samuels, President and CEO
2012
2011
-0-
$107,500
-
-
-
-
-
-
-
-
-0-
$107,500
________________________
 
Our Board of Directors had approved employment agreements for James P.R. Samuels and W. Earl Somerville, our former chief financial officer, with salaries of $215,000 and $150,000 per year, respectively.  We accrued Mr. Samuels’ and Mr. Somerville’s compensation at half of their contract values for the 2010 and 2011 fiscal years.  Mr. Samuels and Mr. Somerville will not receive any payments on accrued compensation until the Company develops or acquires operations and begins to record revenue.  The financial obligation of these employments agreements ceased to accrue as of July 31, 2011.  Mr. Somerville resigned as of November 1, 2011.
 
 
41

 

 
The following table sets forth information concerning unexercised options and equity incentive plan awards on a grant by grant basis for our chief executive officer and any executive officers that earned in excess of $100,000 per annum as of the end of the last completed fiscal year ending July 31, 2012.  The number of options granted and exercise prices have been retroactively restated to reflect the 3-to-1 reverse-stock-split of our common stock.

Outstanding Equity Awards at Fiscal Year-End
  Option Awards
Name
Number of Securities Underlying Unexercised Options
(#) Exercisable
Number of Securities Underlying Unexercised Options
(#) Unexercisable
Equity Incentive Plan Awards: Number of Securities Underlying Unexercised Unearned Options (#)
Option Exercise
Price
($)
Option
Expiration
Date
James P.R. Samuels
100,000 (1)
-
-
$0.015
12/10/2013
125,000 (2)
-
-
$0.11
5/29/2013
133,334 (3)
-
-
$0.24
6/22/2014
133,334 (4)
-
-
$0.18
4/17/2014
___________________________

(1)  
These options were valued using the following assumptions: expected option life: 5 years; risk-free interest rate: 4.97%; annual rate of quarterly dividends: 0.00%; and volatility: 139.92%.
(2)  
These options were valued using the following assumptions: expected option life: 5 years; risk-free interest rate: 4.97%; annual rate of quarterly dividends: 0.00%; and volatility: 336.38%.
(3)  
These options were valued using the following assumptions: expected option life: 7 years; risk-free interest rate: 4.97%; annual rate of quarterly dividends: 0.00%; and volatility: 268.16%.
(4)  
These options were valued using the following assumptions: expected option life: 7 years; risk-free interest rate: 4.97%; annual rate of quarterly dividends: 0.00%; and volatility: 268.16%.

The following table sets forth information regarding the remuneration of our directors, other than those already mentioned in the Summary Compensation Table, during the last completed fiscal year.

Director Compensation
Name
Fees Earned or
Paid in Cash ($)
Stock Awards
($)
Option Awards
($)
All Other Compensation ($)
Total ($)
Frank J. Deleo
-
$9,000.00
-
-
$9,000.00
Robert T. Kane
-
$9,000.00
-
-
$9,000.00
Edward J. Weisberg
-
$9,000.00
-
-
$9,000.00
Gregory Kinney
-
$9,000.00
-
-
$9,000.00

In August 2011, we issued 75,000 shares of our common stock to each of the four directors identified in the table above to compensate them for their services.  The shares were valued at $0.12 per share based on the fair value of the shares in the month they were issued.

Subsequent to the end of the last completed fiscal year, the Company authorized the issuance of 7-year options to purchase100,000 shares of common stock at $0.01 per share to each of the four directors identified in the above table for their services.

Options Exercised in the Last Fiscal Year

No options were exercised in the fiscal year ended July 31, 2012.

Long-Term Incentive Plan Awards

No long-term incentive plan awards were granted in the fiscal year ended July 31, 2012.
 
 
42

 

 
ITEM 12.
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

The following table provides certain information as to the officers and directors, individually and as a group, and the holders of more than 5% of the Common Stock and Preferred Stock on a combined basis, as of October 2, 2012:

Name and Address of
Beneficial Owner (1)
Number of Common
Shares Owned
Number of Preferred
Shares Owned
Total Voting
Shares (2)
Percent of
Class (2)
Rudolf and Monique van den Brink
Rua Ribeira das Vinhas, 4
Apt – 2(dto)
2750-477 Cascais
Portugal
4,668,750 (3)
0
4,668,750
16.4%
James P.R. Samuels
3801 East Florida Avenue, #400
Denver, Colorado  80210
1,726,666 (4)
351,755
3,925,135
14.4%
Dirk Van Keulen
Heemraadslag 14
Gouda, Netherlands  2805DP
454,989 (5)
507,065
3,624,145
13.5%
Donald A. Christensen
48 S Evanston Way
Aurora, Colorado  80012
855,952 (6)
275,268
2,576,377
9.4%
W. Earl Somerville
182 Tilford Road
Oakville, Ontario L6L 4Z3 Canada
1,641,666 (4)
30,117
1,829,897
6.7%
Dirk S. Nye
2119 Larimer St #2
Denver, Colorado  80205
577,190 (7)
144,904
1,482,840
5.4%
Thomas E. McCabe
10108 S Hudson Ave
Tulsa, Oklahoma 74137
750,000 (8)
-0-
750,000
2.8%
Frank J. Deleo
1517 Tennison Parkway
Colleyville, Texas  76034
591,666 (9)
7,500
638,541
2.3%
Robert T. Kane
3620 Main Street
Munhall, Pennsylvania  15120
496,476 (10)
18,997
615,206
2.3%
Edward J. Weisberg
18 Whispering Pine Road
Sudbury, Massachusetts  01776
466,666 (11)
16,697
571,025
2.1%
Gregory Kinney
2107 Geddes Rd.
Rockford, Illinois  61103
229,810 (12)
7,500
276,685
1.0%
All officers and directors as a group
(6 persons)
4,261,284 (13)
402,449
6,776,592
24.9%
_________________
(1)  
To our knowledge, except as set forth in the footnotes to this table and subject to applicable community property laws, each person named in the table has sole voting and investment power with respect to the shares set forth opposite such person’s name.
(2)  
Where persons listed on this table have the right to obtain additional shares of common stock through the exercise or conversion of other securities within 60 days from October 2, 2012, the additional shares are deemed to be outstanding for the purpose of computing the percentage of common stock owned by such persons, but are not deemed to be outstanding for the purpose of computing the percentage owned by any other person.  Percentages are based on 26,847,378 shares of common stock that may be outstanding after
 
 
 
43

 
 
  
conversion or exercise, without further consideration, of our outstanding Preferred Stock.  This amount includes 17,523,984 shares of common stock and 9,323,394 shares of common stock issuable upon exercise of the outstanding Preferred Stock.
(3)  
Includes 1,625,000 shares of common stock issuable upon conversion of outstanding notes.
(4)  
Includes 491,666 shares issuable upon the exercise of vested stock options.
(5)  
Includes 73,334 shares of common stock held by Mr. Van Keulen’s wife and 50,000 shares issuable upon the exercise of vested stock options.
(6)  
Includes 491,666 shares issuable upon the exercise of vested stock options and 214,286 shares issuable upon conversion of outstanding notes.
(7)  
Includes 100,000 shares of common stock held by Mr. Nye’s wife, 20,420 shares of preferred stock held by Mr. Nye’s wife, 316,666 shares issuable upon exercise of vested stock options, and 60,524 shares issuable upon conversion of outstanding notes.
(8)  
Includes 300,000 shares issuable upon exercise of vested stock options.
(9)  
Includes 316,666 shares issuable upon exercise of vested stock options and 125,000 shares issuable upon conversion of outstanding notes.
(10)  
Includes 316,666 shares issuable upon exercise of vested stock options and 29,810 shares issuable upon conversion of outstanding notes.
(11)  
Includes 316,666 shares issuable upon exercise of vested stock options.
(12)  
Includes 50,000 shares issuable upon exercise of vested stock options and 29,810 shares issuable upon conversion of outstanding notes.
(13)  
Includes 1,791,664 shares issuable upon exercise of vested stock options and 184,620 shares issuable upon conversion of outstanding notes.

James P.R. Samuels may be deemed to be the “parent” of our company within the meaning of the rules and regulations of the Securities and Exchange Commission.

Changes in Control

We are not aware of any arrangements that might result in a change in control of the Company.

Equity Compensation Plan Information

The following table sets forth information as of the end of the most recently completed fiscal year, July 31, 2012:
Plan category
Number of securities to be issued
upon exercise of outstanding
options, warrants and rights
Weighted average exercise
price of outstanding options,
warrants and rights
Number of securities remaining
available for future issuance
Equity compensation plans approved by security holders
-0-
-0-
500,000
Equity compensation plans not approved by security holders
3,508,328
$0.16
-0-
Total
3,508,328
$0.16
500,000

Stock Option Plan

By written consent dated May 13, 2005, our shareholders adopted the 2005 Stock Plan.  Under the Plan up to 500,000 shares of our common stock (the “Available Shares”) that may be purchased pursuant to the exercise of incentive stock options, non-qualified stock options, stock grants and stock-based awards (“Stock Rights”) which may be granted to our employees, directors and consultants.  This Plan will terminate on May 13, 2015, unless terminated at an earlier date by vote of the shareholders.

The 2005 Stock Plan is intended to (i) encourage ownership of shares by our employees and directors of and certain consultants to the company; (ii) induce them to work for the benefit of the company; and (iii) provide additional incentive for such persons to promote the success of the company.

 
44

 
As of July 31, 2012, no Stock Rights had been granted under the Plan.

ITEM 13.
CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

Other than described below, none of our present directors, officers or principal shareholders, nor any family member of the foregoing, nor, to the best of our information and belief, any of our former directors, officers or principal shareholders, nor any family member of such former directors, officers or principal shareholders, has or had any material interest, direct or indirect, in any transaction, or in any proposed transaction which has materially affected or will materially affect us.

Accrued Liabilities and Accrued Compensation.  At July 31, 2012 and 2011, $100,044 and $75,764, respectively, was owed to James P.R. Samuels for amounts paid by him on behalf of the Company.  At July 31, 2012, accrued compensation owed to Mr.  Samuels and to W. Earl Somerville totaled $410,625.  In October 2012, the Company reached agreement in principle to settle the accrued salaries and expenses owed Messrs. Samuels and Somerville.  As of September 7, 2012 these amounts totaled $346,926 and 168,801 respectively.  The agreement includes Mr. Samuels and Mr. Somerville forgiving a significant amount and receiving convertible promissory notes.  Ownership of the company’s United Kingdom subsidiary, Worldwide Business Solutions Limited, would also be transferred to Mr. Samuels in this agreement.

Convertible Notes.  In November 2011, Robert Kane and Greg Kinney each loaned $2,087 to the Company to replace convertible notes, with accrued interest, that had matured.  The loans are due October 31, 2012, bear interest at 10% per annum and are convertible into shares of the Company’s common stock at the conversion price of $0.07.

In April 2012, Frank Deleo loaned $5,000 to the Company.  The loan was originally due September 30, 2012 and has subsequently been extended to March 31,2013.  The note bears interest at 10% per annum and is convertible into shares of the Company’s common stock at the conversion price of $.04.

 Interest expense was $406 and $73, respectively, for the years ended July 31 2012 and 2011.

Future Transactions.  All future affiliated transactions will be made or entered into on terms that are no less favorable to us than those that can be obtained from any unaffiliated third party.  A majority of the independent, disinterested members of our board of directors will approve future affiliated transactions.

Director Independence.  Frank J. Deleo, Robert T. Kane, Edward J. Weisberg, and Gregory Kinney are considered independent directors.  We define director independence pursuant to NASDAQ Marketplace Rule 5605(a)(2).

ITEM 14.PRINCIPAL ACCOUNTING FEES AND SERVICES

The fees billed for professional services rendered by our principal accountant are as follows:

FISCAL
 
AUDIT-RELATED
   
YEAR
AUDIT FEES
FEES
TAX FEES
ALL OTHER FEES
2011
$12,000
-0-
-0-
-0-
2012
$10,500
-0-
-0-
-0-

Pre-Approval Policies and Procedures

The Audit Committee must pre-approve any use of our independent accountants for any non-audit services.  All services of our auditors are approved by our whole Board and are subject to review by our whole Board.


 
45

 


PART IV

ITEM 15.EXHIBITS, FINANCIAL STATEMENT SCHEDULES

Regulation
S-K Number
Exhibit
2.1
Share Exchange Agreement by and between Worldwide Strategies Incorporated, Centric Rx, Inc., Jim Crelia, Jeff Crelia, J. Jireh, Inc. and Canada Pharmacy Express, Ltd. dated as of June 28, 2007 (1)
3.1
Amended and Restated Articles of Incorporation (2)
3.2
Amended Bylaws (2)
3.3
Articles of Exchange Pursuant to NRS 92A.200 effective July 31, 2007 (3)
3.4
Certificate of Change Pursuant to NRS 78.209 effective July 31, 2007 (3)
3.5
Certificate of Designation Pursuant to NRS 78.1955 effective December 8, 2008 (4)
3.6
Amendment to Certificate of Designation Pursuant to NRS 78.1955 effective December 15, 2008 (5)
10.1
2005 Stock Plan (2)
10.2
Employment Agreement with James P.R. Samuels dated October 12, 2007 (6)
10.3
Employment Agreement with W. Earl Somerville dated October 12, 2007 (6)
21
List of Subsidiaries (7)
31.1
Rule 13a-14(a) Certification of James P.R. Samuels
31.2
Rule 13a-14(a) Certification of Thomas E. McCabe
32.1
Certification of James P.R. Samuels Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act Of 2002
32.2
Certification of Thomas E. McCabe Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act Of 2002
101.INS
XBRL Instance Document (8)
101.SCH
XBRL Schema Document (8)
101.CAL
XBRL Calculation Linkbase Document (8)
101.LAB
XBRL Label Linkbase Document (8)
101.PRE
XBRL Presentation Linkbase Document(8)
101.DEF
XBRL Taxonomy Extension Definition Linkbase Document (8)
_________________________
 
 
(1)    
Filed as an exhibit to the Current Report on Form 8-K dated June 28, 2007, filed July 2, 2007.
(2)    
Filed as an exhibit to the initial filing of the registration statement on Form SB-2, File No. 333-129398, on November 2, 2005.
(3)    
Filed as an exhibit to the Current Report on Form 8-K dated July 31, 2007, filed August 6, 2007.
(4)    
Filed as an exhibit to the Current Report on Form 8-K dated December 8, 2008, filed December 10, 2008.
(5)    
Filed as an exhibit to the Current Report on Form 8-K dated December 15, 2008, filed December 17, 2008.
(6)    
Filed as an exhibit to the Annual Report on Form 10-KSB, File No. 000-52362, on November 2, 2007.
(7)    
Filed as an exhibit to the Annual Report on Form 10-K, File No. 000-52363, on October 23, 2009.
(8)    
Furnished, not filed. Users of this data submitted electronically herewith are advised pursuant to Rule 406T of Regulation S-T that this interactive data file is deemed not filed or part of a registration statement or prospectus for purposes of sections 11 or 12 of the Securities Act of 1933, is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, and otherwise is not subject to liability under these sections.




 
46

 

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 
WORLDWIDE STRATEGIES INCORPORATED
     
     
     
Date:  October 29, 2012
By:
/s/ James P.R. Samuels
   
James P.R. Samuels
   
Chief Executive Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

Signature
Title
Date
 
 
 
/s/ James P.R. Samuels
Chief Executive Officer and Director
(Principal Executive Officer)
October 29, 2012
James P.R. Samuels
   
/s/ Thomas E. McCabe
Chief Financial Officer, Vice President of
Finance (Principal Financial Officer and
Principal Accounting Officer)
October 29, 2012
Thomas E. McCabe
   
     
 
/s/ Frank J. Deleo
Director
October 29, 2012
Frank J. Deleo
   
     
 
/s/ Robert T. Kane
Director
October 29, 2012
Robert T. Kane
   
     
 
/s/ Edward J. Weisberg
Director
October 29, 2012
Edward J. Weisberg
   
     
 
/s/ Gregory Kinney
Director
October 29, 2012
Gregory Kinney
   

 
47